array:25 [
  "pii" => "S2255553617300277"
  "issn" => "22555536"
  "doi" => "10.1016/j.jpedp.2017.02.014"
  "estado" => "S300"
  "fechaPublicacion" => "2017-09-01"
  "aid" => "477"
  "copyright" => "Sociedade Brasileira de Pediatria"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "J Pediatr (Rio J). 2017;93:467-74"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 971
    "formatos" => array:3 [
      "EPUB" => 119
      "HTML" => 576
      "PDF" => 276
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S0021755717301213"
      "issn" => "00217557"
      "doi" => "10.1016/j.jped.2016.11.006"
      "estado" => "S300"
      "fechaPublicacion" => "2017-09-01"
      "aid" => "477"
      "copyright" => "Sociedade Brasileira de Pediatria"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "J Pediatr (Rio J). 2017;93:467-74"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 841
        "formatos" => array:3 [
          "EPUB" => 98
          "HTML" => 504
          "PDF" => 239
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
        "titulo" => "One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "pt"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "467"
            "paginaFinal" => "474"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "pt" => array:1 [
            "titulo" => "Estudo observacional de um ano da profilaxia com palivizumabe em neonatos com risco para infec&#231;&#227;o por v&#237;rus sincicial respirat&#243;rio na Am&#233;rica Latina"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "pt" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Leandro Martin Castillo, Gabriela Bugarin, Juan Carlos Arias, Jairo Israel Barajas Rangel, Maria Elina Serra, Nestor Vain"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Leandro Martin"
                "apellidos" => "Castillo"
              ]
              1 => array:2 [
                "nombre" => "Gabriela"
                "apellidos" => "Bugarin"
              ]
              2 => array:2 [
                "nombre" => "Juan Carlos"
                "apellidos" => "Arias"
              ]
              3 => array:2 [
                "nombre" => "Jairo Israel"
                "apellidos" => "Barajas Rangel"
              ]
              4 => array:2 [
                "nombre" => "Maria Elina"
                "apellidos" => "Serra"
              ]
              5 => array:2 [
                "nombre" => "Nestor"
                "apellidos" => "Vain"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2255553617300277"
          "doi" => "10.1016/j.jpedp.2017.02.014"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300277?idApp=UINPBA000049"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717301213?idApp=UINPBA000049"
      "url" => "/00217557/0000009300000005/v1_201709220054/S0021755717301213/v1_201709220054/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S2255553617300800"
    "issn" => "22555536"
    "doi" => "10.1016/j.jpedp.2017.07.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-09-01"
    "aid" => "513"
    "copyright" => "Sociedade Brasileira de Pediatria"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:475-81"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 961
      "formatos" => array:3 [
        "EPUB" => 79
        "HTML" => 636
        "PDF" => 246
      ]
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
      "titulo" => "Influence of maternity leave on exclusive breastfeeding"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "475"
          "paginaFinal" => "481"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Influ&#234;ncia da licen&#231;a&#8208;maternidade sobre a amamenta&#231;&#227;o exclusiva"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Fernanda R&#46; Monteiro, Gabriela dos S&#46; Buccini, S&#244;nia I&#46; Ven&#226;ncio, Teresa H&#46;M&#46; da Costa"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Fernanda R&#46;"
              "apellidos" => "Monteiro"
            ]
            1 => array:2 [
              "nombre" => "Gabriela dos S&#46;"
              "apellidos" => "Buccini"
            ]
            2 => array:2 [
              "nombre" => "S&#244;nia I&#46;"
              "apellidos" => "Ven&#226;ncio"
            ]
            3 => array:2 [
              "nombre" => "Teresa H&#46;M&#46; da"
              "apellidos" => "Costa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0021755717306423"
        "doi" => "10.1016/j.jped.2016.11.016"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717306423?idApp=UINPBA000049"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300800?idApp=UINPBA000049"
    "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300800/v1_201709220128/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2255553617300253"
    "issn" => "22555536"
    "doi" => "10.1016/j.jpedp.2017.02.012"
    "estado" => "S300"
    "fechaPublicacion" => "2017-09-01"
    "aid" => "473"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:460-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1602
      "formatos" => array:3 [
        "EPUB" => 104
        "HTML" => 1241
        "PDF" => 257
      ]
    ]
    "pt" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
      "titulo" => "Early amplitude&#8208;integrated electroencephalography for monitoring neonates at high risk for brain injury"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "460"
          "paginaFinal" => "466"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Eletroencefalograma de amplitude integrada precoce no monitoramento de neonatos com risco elevado de les&#227;o cerebral"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1601
              "Ancho" => 1619
              "Tamanyo" => 111796
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o da atividade de fundo nos primeiros tr&#234;s dias de vida em neonatos prematuros com resultado inicial bom e ruim&#46;</p> <p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">DLVP&#44; padr&#227;o descont&#237;nuo de baixa volagem&#59; DHVP&#44; padr&#227;o descont&#237;nuo de alta voltagem&#59; CVP&#44; padr&#227;o de voltagem cont&#237;nua&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Gabriel Fernando Todeschi Variane, Maur&#237;cio Magalh&#227;es, Renato Gasperine, Heitor Castelo Branco Rodrigues Alves, Thiago Luiz Pereira Donoso Scoppetta, Rodrigo de Jesus Gon&#231;alves Figueredo, Francisco Paulo Martins Rodrigues, Alexandre Netto, Marcelo Jenne Mimica, Clery Bernardi Gallacci"
          "autores" => array:10 [
            0 => array:2 [
              "nombre" => "Gabriel Fernando Todeschi"
              "apellidos" => "Variane"
            ]
            1 => array:2 [
              "nombre" => "Maur&#237;cio"
              "apellidos" => "Magalh&#227;es"
            ]
            2 => array:2 [
              "nombre" => "Renato"
              "apellidos" => "Gasperine"
            ]
            3 => array:2 [
              "nombre" => "Heitor Castelo Branco Rodrigues"
              "apellidos" => "Alves"
            ]
            4 => array:2 [
              "nombre" => "Thiago Luiz Pereira Donoso"
              "apellidos" => "Scoppetta"
            ]
            5 => array:2 [
              "nombre" => "Rodrigo de Jesus Gon&#231;alves"
              "apellidos" => "Figueredo"
            ]
            6 => array:2 [
              "nombre" => "Francisco Paulo Martins"
              "apellidos" => "Rodrigues"
            ]
            7 => array:2 [
              "nombre" => "Alexandre"
              "apellidos" => "Netto"
            ]
            8 => array:2 [
              "nombre" => "Marcelo Jenne"
              "apellidos" => "Mimica"
            ]
            9 => array:2 [
              "nombre" => "Clery Bernardi"
              "apellidos" => "Gallacci"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0021755716302595"
        "doi" => "10.1016/j.jped.2016.12.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755716302595?idApp=UINPBA000049"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300253?idApp=UINPBA000049"
    "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300253/v1_201709220128/pt/main.assets"
  ]
  "pt" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
    "titulo" => "One&#8208;year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "467"
        "paginaFinal" => "474"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Leandro Martin Castillo, Gabriela Bugarin, Juan Carlos Arias, Jairo Israel Barajas Rangel, Maria Elina Serra, Nestor Vain"
        "autores" => array:6 [
          0 => array:3 [
            "nombre" => "Leandro Martin"
            "apellidos" => "Castillo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Gabriela"
            "apellidos" => "Bugarin"
            "email" => array:1 [
              0 => "gabriela&#46;bugarin&#64;abbvie&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Juan Carlos"
            "apellidos" => "Arias"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Jairo Israel Barajas"
            "apellidos" => "Rangel"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Maria Elina"
            "apellidos" => "Serra"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Nestor"
            "apellidos" => "Vain"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "AbbVie Inc&#46;&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Casa Madre Canguro Alfa S&#46;A&#46;&#44; Cali&#44; Col&#244;mbia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Hospital General Regional de Le&#243;n&#44; Le&#243;n&#44; Guanajuato&#44; M&#233;xico"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Fundaci&#243;n para la Salud Materno Infantil &#40;Fundasamin&#41;&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Sanatorio de la Trinidad Palermo&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Estudo observacional de um ano da profilaxia com palivizumabe em neonatos com risco para infec&#231;&#227;o por v&#237;rus sincicial respirat&#243;rio na Am&#233;rica Latina"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introdu&#231;&#227;o</span><p id="par0005" class="elsevierStylePara elsevierViewall">As infec&#231;&#245;es do trato respirat&#243;rio inferior &#40;ITRI&#41; s&#227;o a principal causa de doen&#231;as agudas e mortalidade em neonatos e crian&#231;as<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>5 anos&#44; representam aproximadamente 1&#44;4 milh&#227;o de &#243;bitos em todo o mundo em 2010&#46;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">1</span></a> O v&#237;rus sincicial respirat&#243;rio &#40;VSR&#41; &#233; a etiologia mais frequente de doen&#231;as respirat&#243;rias graves&#44; como a bronquiolite e&#47;ou pneumonia&#46;<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">2&#44;3</span></a> Uma metan&#225;lise estimou que pelo menos 33&#44;8 milh&#245;es de epis&#243;dios de ITRI e 66&#46;000 a 199&#46;000 &#243;bitos em crian&#231;as<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>5 anos foram causados por uma infec&#231;&#227;o por VSR em 2005&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">2</span></a> Praticamente 99&#37; dos &#243;bitos por VSR ocorreram em pa&#237;ses em desenvolvimento&#44; nos quais a incid&#234;ncia de ITRI associada ao VSR parece ser mais do que o dobro daquela observada em pa&#237;ses industrializados&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Na Am&#233;rica Latina&#44; uma metan&#225;lise recente estimou preval&#234;ncia de 41&#44;5&#37; &#40;IC de 95&#37;&#44; 32&#44;0&#8208;41&#44;4&#41; de VSR em neonatos de 0&#8208;11 meses com ITRI e estimou que o VSR foi respons&#225;vel por 36&#44;5&#37; &#40;IC de 95&#37;&#44; 28&#44;5&#8208;44&#44;9&#41; das interna&#231;&#245;es em hospitais devido a ITRI entre neonatos de 0 a 11 meses&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">4</span></a> Ademais&#44; uma poss&#237;vel coorte epidemiol&#243;gica de pacientes com<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>18 anos internados devido a ITRIs de 2000 a 2013 em Buenos Aires registrou uma taxa de fatalidade associada ao VSR de 1&#44;9&#37; &#40;74 &#243;bitos&#47;3&#46;888 casos&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">5</span></a> Apesar de essas estimativas indicarem uma urg&#234;ncia das interven&#231;&#245;es relacionadas &#224; sa&#250;de&#44; s&#227;o necess&#225;rios mais estudos para quantificar a carga de doen&#231;a devido ao VSR e os fatores de risco associados &#224;s interna&#231;&#245;es por ITRI em pa&#237;ses da Am&#233;rica Latina&#46;<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">2&#44;4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">V&#225;rios fatores sociais e relacionados ao paciente foram associados ao aumento do risco de infec&#231;&#227;o por VSR&#44; a saber&#44; idade<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>6 meses no in&#237;cio da esta&#231;&#227;o de incid&#234;ncia do VSR&#44; sexo masculino&#44; nascimento m&#250;ltiplo&#44; aglomera&#231;&#227;o em casa&#44; baixa situa&#231;&#227;o socioecon&#244;mica e escolaridade dos pais&#44; frequ&#234;ncia em creche&#44; exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em ambientes fechados e amamenta&#231;&#227;o reduzida&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">6&#44;7</span></a> Al&#233;m disso&#44; alguns quadros cl&#237;nicos est&#227;o associados a doen&#231;as graves e &#224; interna&#231;&#227;o por VSR&#44; inclusive prematuridade &#40;neonatos nascidos com &#8804; 35 semanas de idade gestacional&#41;&#44; displasia broncopulmonar &#40;DBP&#41; e cardiopatia cong&#234;nita hemodinamicamente significativa &#40;CCHS&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">3&#44;8&#8211;10</span></a> Contudo&#44; a import&#226;ncia relativa desses fatores de risco poder&#225; ser diferente na Am&#233;rica Latina&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">O palivizumabe &#40;Synagis&#174;&#59; AbbVie Inc&#44; IL&#44; EUA&#41; &#233; um anticorpo monoclonal humanizado aprovado para a preven&#231;&#227;o de doen&#231;as graves por VSR em beb&#234;s prematuros e jovens crian&#231;as com DBP ou CCHS&#46;<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">11</span></a> Sua seguran&#231;a e efic&#225;cia foram avaliadas em estudos controlados randomizados&#44; testes abertos n&#227;o comparativos e diversos estudos observacionais&#46;<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">12</span></a> Taxas mais baixas de interna&#231;&#245;es por VSR e complica&#231;&#245;es cl&#237;nicas foram relatadas em crian&#231;as que receberam a profilaxia com palivizumabe&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;12&#44;13</span></a> Entretanto&#44; existe uma escassez de dados sobre o uso e a efic&#225;cia do palivizumabe em pa&#237;ses em desenvolvimento&#44; nos quais as taxas de infec&#231;&#227;o por VSR s&#227;o mais elevadas&#44; especificamente em pa&#237;ses da Am&#233;rica Latina&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">12&#44;14&#8211;17</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Este estudo visa a descrever o uso do palivizumabe em neonatos de alto risco e estimar a frequ&#234;ncia de interna&#231;&#227;o por VSR entre neonatos e jovens crian&#231;as tratadas com palivizumabe em pa&#237;ses da Am&#233;rica Latina no per&#237;odo de um ano de acompanhamento ap&#243;s a primeira dose&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">M&#233;todos</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Modelo do estudo</span><p id="par0030" class="elsevierStylePara elsevierViewall">Este foi um estudo multic&#234;ntrico prospectivo e observacional em uma coorte de neonatos em risco devido a infec&#231;&#227;o grave por VSR que receberam palivizumabe durante a circula&#231;&#227;o local de VSR e nos termos da autoriza&#231;&#227;o de venda a respeito de dosagem&#44; popula&#231;&#227;o e indica&#231;&#227;o&#46; O estudo foi feito em 24 locais de sete pa&#237;ses da Am&#233;rica Latina &#40;Argentina&#44; Chile&#44; Col&#244;mbia&#44; Equador&#44; M&#233;xico&#44; Peru e Uruguai&#41;&#46; O recrutamento de indiv&#237;duos come&#231;ou em 19 de fevereiro de 2011 e foi conclu&#237;do em 6 de setembro de 2012&#59; cada indiv&#237;duo foi monitorado por 12 meses&#44; com visitas mensais no per&#237;odo de administra&#231;&#227;o de palivizumabe e&#44; depois&#44; com liga&#231;&#245;es mensais&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Crit&#233;rios de elegibilidade</span><p id="par0035" class="elsevierStylePara elsevierViewall">Em cada local do estudo&#44; beb&#234;s prematuros &#40;nascidos com &#8804; 35 semanas de idade gestacional&#41; ou jovens crian&#231;as com hist&#243;rico de DBP ou CCHS que receberam a primeira dose de palivizumabe nas semanas anteriores &#224; avalia&#231;&#227;o dos crit&#233;rios de inclus&#227;o eram eleg&#237;veis para participar&#46; Crian&#231;as exclu&#237;das da administra&#231;&#227;o de palivizumabe segundo a pr&#225;tica local n&#227;o participaram&#46; Os pais ou respons&#225;veis legais dos neonatos e jovens crian&#231;as inclu&#237;dos forneceram um consentimento informado por escrito&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Acompanhamento e coleta de dados</span><p id="par0040" class="elsevierStylePara elsevierViewall">Os indiv&#237;duos inscritos foram acompanhados por um ano ap&#243;s sua primeira dose de palivizumabe&#46; Dados epidemiol&#243;gicos e cl&#237;nicos&#44; informa&#231;&#245;es sobre a ades&#227;o de pacientes&#44; interna&#231;&#245;es e dados de seguran&#231;a foram coletados mensalmente de acordo com a pr&#225;tica cl&#237;nica de rotina&#44; por meio de avalia&#231;&#245;es no consult&#243;rio durante os quatro primeiros meses&#46; Ap&#243;s os quatro primeiros meses&#44; ocorreram visitas de monitoramento de seis e 12 meses e liga&#231;&#245;es de acompanhamento nos meses 5&#44; 7&#44; 8&#44; 9&#44; 10 e 11 ap&#243;s a inclus&#227;o do indiv&#237;duo no estudo&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">O hist&#243;rico de sa&#250;de de cada paciente e a exposi&#231;&#227;o a fatores de risco ambiental foram coletados e foi feito um exame f&#237;sico em cada visita ao consult&#243;rio para o estudo&#46; Eventos adversos e interna&#231;&#245;es ocorridas desde a visita anterior tamb&#233;m foram registrados&#46; A ITRI foi definida como pneumonia&#44; bronquiolite ou pieira de acordo com o diagn&#243;stico cl&#237;nico&#46; Foram coletadas amostras nasais e faringianas para o teste de VSR apenas quando recomendado pelas diretrizes cl&#237;nicas locais e&#47;ou mediante decis&#227;o do m&#233;dico&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">As crian&#231;as podiam receber at&#233; cinco doses de palivizumabe&#44; de acordo com a prescri&#231;&#227;o do m&#233;dico&#46; A ades&#227;o dos pacientes ao tratamento foi calculada como o n&#250;mero de doses de palivizumabe recebidas em compara&#231;&#227;o com o n&#250;mero esperado de doses&#46; O n&#250;mero esperado de doses para cada paciente foi estimado com base na sazonalidade e nas diretrizes atuais de cada pa&#237;s&#46; Foi feita uma an&#225;lise do intervalo entre doses &#40;nos casos em que a data de cada dose estava dispon&#237;vel&#41; e os intervalos de 30 &#40;&#177; 5&#41; dias foram considerados em conformidade&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">An&#225;lise de seguran&#231;a</span><p id="par0055" class="elsevierStylePara elsevierViewall">Os eventos adversos foram classificados com base na classifica&#231;&#227;o do sistema da vers&#227;o 16&#46;0 do Dicion&#225;rio M&#233;dico para Atividades Regulat&#243;rias&#46; Eventos adversos graves foram definidos como qualquer evento adverso que tenha resultado em &#243;bito&#44; situa&#231;&#227;o de risco de vida&#44; interna&#231;&#227;o do paciente&#44; defici&#234;ncia ou incapacidade persistente ou significativa ou em outros eventos clinicamente relevantes&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">An&#225;lise estat&#237;stica</span><p id="par0060" class="elsevierStylePara elsevierViewall">Foi estimado um tamanho m&#237;nimo de amostra de 400 pacientes com base no poss&#237;vel n&#250;mero de pacientes que recebiam palivizumabe em cada pa&#237;s para permitir a estimativa da propor&#231;&#227;o de ITRIs com intervalo de confian&#231;a &#40;IC&#41; de 95&#37;&#44; com precis&#227;o estimada de 3&#37;&#46; Toda a an&#225;lise de dados foi feita com o Stata &#40;StataCorp&#46; 2007&#46;&#160;Stata Software estat&#237;stico&#58; vers&#227;o 10&#46; TX&#44; EUA&#41;&#46; As frequ&#234;ncias e percentuais de vari&#225;veis categ&#243;ricas e as medidas da posi&#231;&#227;o central e da dispers&#227;o de vari&#225;veis quantitativas foram usadas para descrever as caracter&#237;sticas dos indiv&#237;duos da amostra&#44; o uso de palivizumabe e os eventos adversos mais comuns&#46; Foi estimado um IC de 95&#37; para as propor&#231;&#245;es ou taxas de incid&#234;ncia dos resultados relevantes&#46; Foram usados modelos lineares generalizados para estimar as taxas anuais de interna&#231;&#227;o por ITRI&#46; Os modelos de regress&#227;o de Poisson foram aplicados para identificar os fatores de risco das interna&#231;&#245;es por ITRI e as caracter&#237;sticas b&#225;sicas como idade&#44; sexo&#44; peso ao nascer e comorbidades foram inclu&#237;das como covari&#225;veis&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Este estudo foi feito de acordo com a Declara&#231;&#227;o de Helsinque&#46; O protocolo foi aprovado por comit&#234;s &#233;ticos institucionais independentes antes do in&#237;cio e segundo a legisla&#231;&#227;o nacional&#46; Foi obtido o consentimento informado por escrito de no m&#237;nimo um pai ou respons&#225;vel legal de todos os pacientes&#46;</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Resultados</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Caracter&#237;sticas da amostra</span><p id="par0070" class="elsevierStylePara elsevierViewall">Foram inscritos 464 neonatos e jovens crian&#231;as de 24 locais de sete pa&#237;ses da Am&#233;rica Latina&#44; dos quais seis foram exclu&#237;das devido &#224; aus&#234;ncia de visitas de acompanhamento adicionais &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>4&#41;&#44; consentimento informado inv&#225;lido &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#41; e administra&#231;&#227;o de palivizumabe na esta&#231;&#227;o anterior &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#41;&#46; Assim&#44; 458 neonatos e jovens crian&#231;as foram inclu&#237;dos e 397 &#40;86&#44;7&#37;&#41; completaram um ano de acompanhamento&#46; Entre os 61 neonatos e jovens crian&#231;as que n&#227;o conclu&#237;ram o acompanhamento&#44; 43 &#40;70&#44;5&#37;&#41; deixaram de ser acompanhados&#44; seis &#40;9&#44;8&#37;&#41; retiraram o consentimento do estudo&#44; tr&#234;s &#40;4&#44;9&#37;&#41; faleceram por motivos n&#227;o relacionados a doen&#231;as respirat&#243;rias e nove &#40;29&#44;4&#37;&#41; n&#227;o conclu&#237;ram o estudo por outros motivos&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Os dados demogr&#225;ficos dos neonatos e das jovens crian&#231;as inclu&#237;dos s&#227;o apresentados na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#59; 52&#37; dos pacientes eram do sexo masculino&#46; O peso m&#233;dio ao nascer era de 1&#46;345<span class="elsevierStyleHsp" style=""></span>g &#40;desvio padr&#227;o &#91;DP&#93; 460&#41; e a idade gestacional mediana era de 31 semanas &#40;varia&#231;&#227;o de 23&#8208;39 semanas&#41;&#46; Quase todos os pacientes do estudo &#40;98&#44;2&#37;&#41; foram prematuros&#59; 29&#44;2&#37; dos pacientes apresentavam DBP e 10&#44;1&#37;&#44; CCHS&#46; Al&#233;m disso&#44; a prematuridade com DBP e&#47;ou CCHS foi observada em 33&#44;4&#37; dos pacientes&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Uso e ades&#227;o do paciente ao palivizumabe</span><p id="par0080" class="elsevierStylePara elsevierViewall">O motivo mais frequente da indica&#231;&#227;o de palivizumabe foi a prematuridade &#40;por si mesma ou em conjunto com outras indica&#231;&#245;es&#41; &#40;98&#44;0&#37;&#41;&#46; O n&#250;mero total de doses administradas foi de 1&#46;744 em 458 pacientes&#44; corresponde a 3&#44;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;3 doses por paciente em m&#233;dia&#46; De maneira geral&#44; os pacientes receberam 83&#44;7&#37; &#40;IC de 95&#37;&#44; 80&#44;8&#8208;86&#44;5&#41; de suas doses esperadas&#44; com base na sazonalidade e nas atuais diretrizes de cada pa&#237;s&#44; e 78&#44;4&#37; dos 1&#46;249 intervalos entre doses foram classificados como aderentes &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#41;&#46; O tempo m&#233;dio entre o in&#237;cio da profilaxia com palivizumabe e o desenvolvimento de ITRI devido ao VSR foi de 75&#44;7 dias&#44; com mediana de 44 dias&#46;</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Interna&#231;&#245;es devido &#224; ITRI</span><p id="par0085" class="elsevierStylePara elsevierViewall">Ocorreram 61 epis&#243;dios de ITRI que exigiram interna&#231;&#227;o em 52 crian&#231;as &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">tabela 2</a>&#41;&#46; A taxa de interna&#231;&#227;o devida a ITRI foi de 14&#44;6 em cada 100 pacientes&#8208;anos &#40;IC de 95&#37;&#44; 10&#44;5&#8208;18&#44;6&#41;&#46; A infec&#231;&#227;o por VSR foi confirmada em 12 epis&#243;dios em 12 neonatos e a taxa de interna&#231;&#227;o associada ao VSR foi de 2&#44;9 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 1&#44;3&#8208;4&#44;5&#41;&#46; Nenhuma das interna&#231;&#245;es por VSR exigiu apoio respirat&#243;rio&#46; Dos 12 casos de interna&#231;&#227;o associada ao VSR&#44; todos eram beb&#234;s prematuros e dez apresentaram outro fator de risco&#58; nove eram pacientes com DBP e um apresentava CCHS&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Foram feitas an&#225;lises univariadas e multivariadas para identificar os fatores de risco da interna&#231;&#227;o por LRTI &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">tabela 3</a>&#41;&#46; Na an&#225;lise univariada&#44; um n&#237;vel mais baixo de escolaridade materna e a DBP provaram aumentar o risco de interna&#231;&#227;o por ITRI em uma popula&#231;&#227;o que recebeu a profilaxia com palivizumabe&#46; Na an&#225;lise do modelo multivariado&#44; apenas a DBP foi confirmada como fator de risco independente &#40;raz&#227;o de taxas de incid&#234;ncia &#40;RTI&#41; ajustada&#44; 2&#44;77&#41;&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">An&#225;lises adicionais foram feitas no subgrupo de 134 pacientes com DBP&#59; 28 pacientes com DBP apresentaram 32 epis&#243;dios de interna&#231;&#227;o relacionada a ITRI e nove epis&#243;dios foram confirmados como relacionados &#224; infec&#231;&#227;o por VSR&#46; A taxa de interna&#231;&#227;o devida a ITRI foi de 26&#44;4 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 17&#44;1&#8208;35&#44;8&#41; e a taxa de interna&#231;&#227;o devida ao VSR foi de 7&#44;4 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 2&#44;7&#8208;12&#44;1&#41;&#46;</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Eventos adversos durante o tratamento com palivizumabe</span><p id="par0100" class="elsevierStylePara elsevierViewall">Foram registrados 1&#46;165 eventos adversos durante um ano de acompanhamento&#59; 102 pacientes &#40;22&#44;3&#37;&#41; apresentaram 135 eventos adversos graves&#46; A <a class="elsevierStyleCrossRef" href="#tbl0020">tabela 4</a> apresenta os eventos adversos n&#227;o graves &#40;&#8805; 5&#37; dos pacientes&#41; relatados no estudo &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>299&#41;&#46; Dos eventos adversos graves relatados&#44; o mais comum &#40;&#8805; 5&#37; dos pacientes&#41; foi a bronquiolite &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>28&#59; 6&#44;1&#37;&#41;&#46; Adicionalmente&#44; 92 eventos adversos graves &#40;68&#44;1&#37;&#41; resultaram em ou prolongaram o tempo de interna&#231;&#227;o&#44; 29 &#40;21&#44;4&#37;&#41; foram classificados pelo investigador como clinicamente relevantes e 11 &#40;8&#44;1&#37;&#41; foram possivelmente fatais&#46; Tr&#234;s &#243;bitos &#40;2&#44;2&#37;&#41; foram registrados durante o acompanhamento e n&#227;o foram considerados relacionados ao tratamento com palivizumabe ou &#224; infec&#231;&#227;o por VSR&#46; Foram relatados seis eventos de dor no local da inje&#231;&#227;o ap&#243;s a administra&#231;&#227;o de palivizumabe em tr&#234;s pacientes&#46; N&#227;o ocorreram eventos adversos graves considerados relacionados ao palivizumabe&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Discuss&#227;o</span><p id="par0105" class="elsevierStylePara elsevierViewall">O palivizumabe &#233; aprovado para a profilaxia de doen&#231;a grave por VSR&#44; com efic&#225;cia comprovada na redu&#231;&#227;o de interna&#231;&#245;es de neonatos de alto risco&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;13</span></a> Contudo&#44; uma profilaxia consistente pode ser desafiadora devido a diversos fatores m&#233;dicos e socioecon&#244;micos da crian&#231;a&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">18&#44;19</span></a> Este estudo apresentou uma descri&#231;&#227;o prospectiva do uso e da efic&#225;cia do palivizumabe nos pa&#237;ses da Am&#233;rica Latina&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">A taxa de interna&#231;&#245;es por VSR observada no estudo &#40;2&#44;9 em cada 100 pacientes&#8208;ano&#41; &#233; baixa e est&#225; no intervalo relatado com rela&#231;&#227;o ao palivizumabe em diferentes ensaios cl&#237;nicos &#40;0&#44;0&#8208;5&#44;3&#37;&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;13&#44;20</span></a> Adicionalmente&#44; os resultados deste estudo tamb&#233;m s&#227;o compat&#237;veis com os de outros estudos observacionais &#40;1&#44;3&#8208;2&#44;9 epis&#243;dios em cada 100 pacientes&#8208;ano&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">12&#44;21&#44;22</span></a> Por outro lado&#44; existem poucos dados sobre as taxas de interna&#231;&#227;o por VSR em neonatos sem a profilaxia com palivizumabe na Am&#233;rica Latina&#46; Um estudo de um hospital p&#250;blico da Argentina mostrou que neonatos sem a profilaxia com palivizumabe apresentaram taxas de interna&#231;&#227;o por VSR&#8208;ITRI de 26&#37; e 29&#37; em duas coortes hist&#243;ricas&#46;<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">23</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Foi mostrado que as taxas de interna&#231;&#227;o por VSR em pacientes com profilaxia com palivizumabe podem chegar a 7&#44;6&#37; em algumas circunst&#226;ncias&#44; principalmente em pacientes com DBP&#46;<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">13&#44;18&#44;23</span></a> De fato&#44; neste estudo&#44; uma taxa de interna&#231;&#227;o por VSR de 7&#44;4 em cada 100 pacientes&#8208;ano foi observada em crian&#231;as com DBP&#44; achado em linha com resultados relatados anteriormente&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">18</span></a> A mediana do tempo de interna&#231;&#227;o devido a doen&#231;as causadas pelo VSR foi de sete dias&#44; resultado semelhante &#224;quele observado em estudos de outros pa&#237;ses<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">22&#44;24</span></a> e a achados do estudo de Bauer et al&#46; em um &#250;nico centro na Argentina&#46;<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">23</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">A incid&#234;ncia e a gravidade da infec&#231;&#227;o por VSR em neonatos prematuros foram associadas a diversos fatores&#44; como a presen&#231;a de irm&#227;os em casa e frequ&#234;ncia em creche&#44; entre outros&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">6&#44;25</span></a> Um estudo de coorte prospectivo com 152 neonatos internados por ITRI mostrou que o baixo peso ao nascer&#44; o baixo n&#237;vel de escolaridade da m&#227;e e as baixas condi&#231;&#245;es socioecon&#244;micas eram fatores de risco associados &#224;s interna&#231;&#245;es por VSR em neonatos prematuros e nascidos a termo sem instabilidade hemodin&#226;mica&#44; doen&#231;as card&#237;acas ou doen&#231;a pulmonar cr&#244;nica no Brasil&#46;<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">26</span></a> Na Argentina&#44; Bauer et al&#46; tamb&#233;m observaram que crian&#231;as com menos de 10 anos em casa e m&#227;es que n&#227;o conclu&#237;ram o ensino fundamental estavam associadas ao aumento do risco de interna&#231;&#227;o por VSR entre neonatos prematuros com e sem DBP&#46;<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">27</span></a> Ademais&#44; alguns estudos mostraram aumento no risco de ITRI devido &#224; exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em casa&#44; embora seja necess&#225;ria uma pesquisa adicional para determinar seu impacto sobre a gravidade da ITRI por VSR&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">6</span></a> No presente estudo&#44; apenas a DBP foi identificada como fator de risco independente da interna&#231;&#227;o por ITRI&#44; ao passo que outros fatores n&#227;o estavam associados ao aumento do risco&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">No que diz respeito &#224; seguran&#231;a&#44; nenhum evento adverso grave relacionado ao palivizumabe foi relatado em nosso estudo&#46; O padr&#227;o e o tipo de eventos adversos foram compat&#237;veis com o perfil de seguran&#231;a conhecido do palivizumabe&#44; que normalmente reflete os problemas m&#233;dicos subjacentes desses pacientes&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;12&#44;18&#44;28</span></a> De maneira semelhante a outros estudos&#44; as infec&#231;&#245;es respirat&#243;rias do trato superior foram os eventos adversos mais frequentes&#44; com propor&#231;&#227;o compar&#225;vel &#224;quela relatada em um estudo brasileiro &#40;59&#44;4&#37; em compara&#231;&#227;o com 52&#44;8&#37; em nosso estudo&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">29</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Este estudo teve algumas limita&#231;&#245;es&#44; como ocorre em estudos observacionais&#46; Como n&#227;o teve controle&#44; n&#227;o fornece uma estimativa t&#227;o clara do impacto da profilaxia com palivizumabe como os resultados obtidos por meio de ensaios cl&#237;nicos comparativos randomizados&#46;<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">24</span></a> Al&#233;m disso&#44; nem todas as interna&#231;&#245;es passaram por um exame diagn&#243;stico para confirmar se o epis&#243;dio foi causado por uma infec&#231;&#227;o por VSR&#46; Contudo&#44; como o teste de VSR depende das diretrizes locais e n&#227;o era sempre feito&#44; esses resultados devem ser interpretados com cautela&#46; Isso ocorre devido principalmente &#224; variabilidade entre os locais participantes no que diz respeito &#224;s diretrizes locais sobre testes de diagn&#243;stico&#44; limita&#231;&#227;o que tamb&#233;m estava presente em estudos semelhantes do mundo real&#46;<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">21&#44;24&#44;30</span></a> A falta de informa&#231;&#245;es tamb&#233;m pode ser um fator em alguns casos em que a interna&#231;&#227;o ocorreu em um hospital n&#227;o envolvido no estudo&#46; Contudo&#44; foram envidados esfor&#231;os para coletar dados a respeito da presen&#231;a de VSR nesses casos&#46; Por fim&#44; outra limita&#231;&#227;o foi que eventos adversos n&#227;o graves n&#227;o foram classificados pelos investigadores como relacionados ou n&#227;o ao palivizumabe&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">Embora os locais participantes n&#227;o representem totalmente a popula&#231;&#227;o geral de pacientes que recebem a profilaxia em pa&#237;ses da Am&#233;rica Latina&#44; eles foram selecionados com base em sua capacidade de inscri&#231;&#245;es e experi&#234;ncia com o palivizumabe e o tratamento de crian&#231;as de alto risco&#46; Por outro lado&#44; como os pais das crian&#231;as precisavam ter acesso ao sistema de sa&#250;de&#44; um vi&#233;s de sele&#231;&#227;o pode afetar algumas vari&#225;veis&#44; como a ades&#227;o ao tratamento e o n&#237;vel de escolaridade&#44; que de outra forma poderiam estar associadas &#224;s interna&#231;&#245;es por ITRI&#46; Por fim&#44; embora a incid&#234;ncia e a gravidade da infec&#231;&#227;o por VSR sejam afetadas pela sazonalidade&#44;<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">25</span></a> isso n&#227;o deve comprometer os principais achados&#46; Este estudo foi feito durante dois anos consecutivos &#40;incluindo mais de uma esta&#231;&#227;o de VSR&#41; em diferentes cidades e pa&#237;ses&#44; fornece&#44; assim&#44; uma vis&#227;o geral da regi&#227;o da Am&#233;rica Latina&#44; ao mesmo tempo em que abrange a maioria de seus padr&#245;es de sazonalidade de VSR&#46; Na verdade&#44; at&#233; onde sabemos&#44; este &#233; o primeiro estudo multic&#234;ntrico que incluiu neonatos que receberam profilaxia na regi&#227;o da Am&#233;rica Latina&#44; com a vantagem da coleta de dados demogr&#225;ficos e cl&#237;nicos completos de praticamente todas as crian&#231;as inscritas&#44; embora outros estudos em um &#250;nico centro e com um acompanhamento mais curto tenham sido feitos nessa regi&#227;o&#46;</p><p id="par0140" class="elsevierStylePara elsevierViewall">A taxa de interna&#231;&#227;o devida a infec&#231;&#227;o por VSR foi baixa nessa popula&#231;&#227;o e em linha com as observadas em v&#225;rios ensaios cl&#237;nicos controlados randomizados e estudos observacionais&#46; Com base em nosso estudo&#44; a profilaxia com palivizumabe &#233; eficaz e tem um bom perfil de seguran&#231;a em neonatos da Am&#233;rica Latina com alto risco de infec&#231;&#227;o grave por VSR&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Financiamento</span><p id="par0145" class="elsevierStylePara elsevierViewall">Este estudo foi financiado por AbbVie&#44; Inc&#46;</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Conflitos de interesse</span><p id="par0150" class="elsevierStylePara elsevierViewall">N Vain recebeu uma bolsa&#47;apoio &#224; pesquisa e honor&#225;rios de palestrante e consultoria da AbbVie&#46; M E Serra &#233; funcion&#225;ria da Fundasamin&#44; contratada pela AbbVie para Gest&#227;o de Dados do Estudo&#46; A AbbVie Inc&#46; esteve envolvida no modelo do estudo&#59; na coleta&#44; an&#225;lise e interpreta&#231;&#227;o de dados&#59; e na prepara&#231;&#227;o e aprova&#231;&#227;o deste manuscrito&#46; L&#46; Castillo e G&#46; Bugarin s&#227;o funcion&#225;rios da AbbVie e podem deter a&#231;&#245;es ou op&#231;&#245;es&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:12 [
        0 => array:3 [
          "identificador" => "xres904278"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Objective"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Method"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec884873"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres904279"
          "titulo" => "Resumo"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Objetivo"
            ]
            1 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "M&#233;todo"
            ]
            2 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Conclus&#245;es"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec884874"
          "titulo" => "Palavras&#8208;chave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introdu&#231;&#227;o"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "M&#233;todos"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Modelo do estudo"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Crit&#233;rios de elegibilidade"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Acompanhamento e coleta de dados"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "An&#225;lise de seguran&#231;a"
            ]
            4 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "An&#225;lise estat&#237;stica"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0040"
          "titulo" => "Resultados"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Caracter&#237;sticas da amostra"
            ]
            1 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Uso e ades&#227;o do paciente ao palivizumabe"
            ]
            2 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Interna&#231;&#245;es devido &#224; ITRI"
            ]
            3 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Eventos adversos durante o tratamento com palivizumabe"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Discuss&#227;o"
        ]
        8 => array:2 [
          "identificador" => "sec0070"
          "titulo" => "Financiamento"
        ]
        9 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conflitos de interesse"
        ]
        10 => array:2 [
          "identificador" => "xack301132"
          "titulo" => "Agradecimentos"
        ]
        11 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-07-26"
    "fechaAceptado" => "2016-11-09"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec884873"
          "palabras" => array:5 [
            0 => "Palivizumab"
            1 => "Prophylaxis"
            2 => "Respiratory syncytial virus"
            3 => "Lower respiratory tract infection"
            4 => "Latin America"
          ]
        ]
      ]
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras&#8208;chave"
          "identificador" => "xpalclavsec884874"
          "palabras" => array:5 [
            0 => "Palivizumabe"
            1 => "Profilaxia"
            2 => "V&#237;rus sincicial respirat&#243;rio"
            3 => "Infec&#231;&#227;o do trato respirat&#243;rio inferior"
            4 => "Am&#233;rica Latina"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">This study aims to describe real world palivizumab use and effectiveness in high&#8208;risk Latin American infants and young children&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Method</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Prospective&#44; multicenter observational study with infants at risk for severe RSV infection who received palivizumab according to routine clinical practice&#46; Subjects were followed for one year with monthly visits after the first dose of palivizumab&#46; An infant was considered adherent if receiving all the expected injections or five or fewer injections within appropriate inter&#8208;dose intervals&#46; Annual incidence rates and risk factors of lower respiratory tract infection &#40;LRTI&#41; hospitalization were determined through Poisson regression models &#40;<span class="elsevierStyleItalic">&#945;</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#41;&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The study enrolled 458 children from seven countries in Latin America&#44; from February 2011 to September 2012&#46; The majority &#40;98&#37;&#41; were born &#60;36 weeks gestation&#46; Overall&#44; patients received 83&#46;7&#37; of their expected injections and 86&#46;7&#37; completed one year of follow&#8208;up&#46; Of the 61 LRTI hospitalizations&#44; 12 episodes were due to RSV infection&#46; The RSV&#8208;associated hospitalization rate was 2&#46;9 per 100 patient&#8208;years&#46; Bronchopulmonary dysplasia was identified as an independent risk factor for LRTI hospitalization&#46; A total of 1165 adverse events were recorded during one year of follow&#8208;up&#46; One hundred and two patients &#40;22&#46;3&#37;&#41; had a total of 135 serious adverse events&#44; but no events were considered to be related to palivizumab&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The rate of RSV hospitalization in high&#8208;risk infants in Latin America was low and aligned with those observed in randomized control trials and observational studies&#46; Palivizumab prophylaxis appeared effective and had a good safety profile in this population&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Objective"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Method"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "pt" => array:3 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Descrever o uso e a efic&#225;cia do palivizumabe no mundo real em neonatos e jovens crian&#231;as de alto risco latino&#8208;americanas&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">M&#233;todo</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Estudo observacional prospectivo multic&#234;ntrico com neonatos em risco devido a infec&#231;&#227;o grave por VSR que receberam palivizumabe de acordo com a pr&#225;tica cl&#237;nica de rotina&#46; Os indiv&#237;duos foram acompanhados por um ano&#44; com visitas mensais ap&#243;s a primeira dose de palivizumabe&#46; Um neonato foi considerado adepto se recebeu todas as inje&#231;&#245;es esperadas ou &#8804; 5 inje&#231;&#245;es nos intervalos entre doses adequados&#46; As taxas de incid&#234;ncia anuais e os fatores de risco de interna&#231;&#227;o por infec&#231;&#227;o do trato respirat&#243;rio inferior &#40;ITRI&#41; foram determinados por meio dos modelos de regress&#227;o de Poisson &#40;&#945;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#41;&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">O estudo inscreveu 458 crian&#231;as de sete pa&#237;ses da Am&#233;rica Latina&#44; de fevereiro de 2011 a setembro de 2012&#46; A maioria &#40;98&#37;&#41; nasceu com &#60; 36 semanas&#46; Em geral&#44; os pacientes receberam 83&#44;7&#37; de suas inje&#231;&#245;es esperadas e 86&#44;7&#37; completaram um ano de acompanhamento&#46; Das 61 interna&#231;&#245;es por ITRI&#44; 12 epis&#243;dios foram devidos a infec&#231;&#227;o por VSR&#46; A taxa de interna&#231;&#227;o associada ao VSR foi de 2&#44;9 em cada 100 pacientes&#8208;ano&#46; A displasia broncopulmonar foi identificada como um fator de risco independente da interna&#231;&#227;o por ITRI&#46; Foram registrados 1&#46;165 eventos adversos durante um ano de acompanhamento&#59; 122 &#40;22&#44;3&#37;&#41; apresentaram 135 eventos adversos graves&#44; por&#233;m nenhum deles foi considerado relacionado ao palivizumabe&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclus&#245;es</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">A taxa de interna&#231;&#227;o por VSR em neonatos de alto risco na Am&#233;rica Latina foi baixa e em linha com as observadas em ensaios cl&#237;nicos controlados randomizados e estudos observacionais&#46; A profilaxia com palivizumabe pareceu eficaz e com bom perfil de seguran&#231;a nessa popula&#231;&#227;o&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Objetivo"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "M&#233;todo"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Conclus&#245;es"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0040">Como citar este artigo&#58; Castillo LM&#44; Bugarin G&#44; Arias JC&#44; Rangel JI&#44; Serra ME&#44; Vain N&#46; One&#8208;year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America&#46; J Pediatr &#40;Rio J&#41;&#46; 2017&#59;93&#58;467&#8211;74&#46;</p>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">CC&#58; cardiopatia cong&#234;nita&#59; DBP&#44; displasia broncopulmonar&#59; DP&#58; desvio padr&#227;o&#59; IIQ&#58; intervalo interquartil&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Pa&#237;s de inscri&#231;&#227;o&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Argentina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">149 &#40;32&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Col&#244;mbia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">147 &#40;32&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>M&#233;xico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100 &#40;21&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Chile&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32 &#40;7&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Peru&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;2&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Uruguai&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 &#40;2&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Equador&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;1&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Masculino&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">239 &#40;52&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade &#40;dias&#41; na primeira dose&#44; mediana &#40;IIQ&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55 &#40;31&#8208;99&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Peso ao nascer &#40;g&#41;&#44; m&#233;dia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#177;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">DP</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1344&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>460&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;&#44; mediana &#40;IIQ&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31 &#40;28&#8208;32&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">287 &#40;62&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 29 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">118 &#40;25&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>29&#8208;32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">169 &#40;36&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>32&#8208;35 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">163 &#40;35&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#62; 35 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8 &#40;1&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Prematuridade&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">449 &#40;98&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Somente prematuridade&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">296 &#40;64&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">112 &#40;24&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;3&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP e&#47;ou CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">153 &#40;33&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DBP&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">134 &#40;29&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">CC&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46 &#40;10&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">M&#227;e com primeiro grau completo&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">443 &#40;96&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Tabagismo durante a gravidez&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;19&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">M&#227;e asm&#225;tica&#47;at&#243;pica&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55 &#40;12&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Nascimento m&#250;ltiplo&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">141 &#40;30&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Amamenta&#231;&#227;o aos 3 meses de idade</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">222 &#40;49&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Outras crian&#231;as na casa &#8804; 6 anos&#44; n &#40;5&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">160 &#40;34&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em casa&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">78 &#40;17&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Frequ&#234;ncia em creche&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 &#40;1&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Assist&#234;ncia m&#233;dica pr&#233;&#8208;natal</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">386 &#40;84&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Interna&#231;&#227;o na unidade de terapia intensiva neonatal&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">447 &#40;97&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Ventila&#231;&#227;o mec&#226;nica neonatal&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">257 &#40;56&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Ades&#227;o ao tratamento com palivizumabe&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">383 &#40;83&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Doses administradas por paciente&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>5 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">200 &#40;43&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>4 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">66 &#40;14&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>3 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">130 &#40;28&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>2 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28 &#40;6&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>1 dose&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">34 &#40;7&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Pacientes recebendo as doses esperadas&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Acima do esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">29 &#40;6&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Como esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">240 &#40;52&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Abaixo do esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">189 &#40;41&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Fornecedor do palivizumabe &#40;n</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#61;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">1&#46;707 doses&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Plano de sa&#250;de privado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">814 &#40;47&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Sistema p&#250;blico de sa&#250;de&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">669 &#40;39&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Previd&#234;ncia social&#47;Sociedade de Apoio M&#250;tuo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">207 &#40;12&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Desembolsado pelo paciente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;1&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520458.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">A amamenta&#231;&#227;o foi analisada aos tr&#234;s meses de 449 pacientes&#58; 222 neonatos &#40;49&#44;4&#37;&#41; recebiam amamenta&#231;&#227;o&#44; com 49 neonatos &#40;10&#44;9&#37;&#41; que recebiam apenas amamenta&#231;&#227;o e 173 neonatos &#40;38&#44;5&#37;&#41; que recebiam amamenta&#231;&#227;o n&#227;o exclusiva&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">A assist&#234;ncia m&#233;dica pr&#233;&#8208;natal foi definida como quatro ou mais consultas m&#233;dicas durante a gravidez&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas demogr&#225;ficas&#44; cl&#237;nicas e de tratamento da popula&#231;&#227;o estudada &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>458&#41;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabela 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">CC&#58; cardiopatia cong&#234;nita&#59; DBP&#58; displasia broncopulmonar&#59; DP&#58; desvio padr&#227;o&#59; IC&#58; intervalo de confian&#231;a&#59; ITRI&#58; infec&#231;&#227;o do trato respirat&#243;rio inferior&#59; VSR&#58; v&#237;rus sincicial respirat&#243;rio&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Epis&#243;dios de ITRI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Epis&#243;dios de ITRI relacionados ao VSR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Crian&#231;as com no m&#237;nimo uma interna&#231;&#227;o&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&#47;458 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#47;458 &#40;2&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Taxa de interna&#231;&#227;o &#40;IC de 95&#37;&#41; a cada 100 pacientes&#44; anos</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#44;6 &#40;10&#44;5&#8208;18&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;9 &#40;1&#44;3&#8208;4&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">N&#250;mero de interna&#231;&#245;es</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Tempo de interna&#231;&#227;o &#40;dias&#41;</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">mediana &#40;faixa&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 &#40;1&#8208;43&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;5&#8208;21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Apoio respirat&#243;rio</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4 &#40;6&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;</span>&#44;<a class="elsevierStyleCrossRefs" href="#tblfn0015"><span class="elsevierStyleSup">a&#44;b</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41 &#40;67&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6 &#40;50&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 29 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20 &#40;32&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4 &#40;33&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>30&#8208;31 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21 &#40;34&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2 &#40;16&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>32&#8208;34 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20 &#40;32&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6 &#40;50&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DBP</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32 &#40;52&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;75&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">CC</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;8&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade no epis&#243;dio &#40;dias&#41;</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">m&#233;dia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#177;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">DP</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">236&#44;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">224&#44;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>115&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520459.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Os percentuais foram calculados pelo total de epis&#243;dios de interna&#231;&#227;o devido a ITRI &#40;geral e relacionada ao VSR&#41;&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Todos os pacientes com epis&#243;dios de ITRI tinham idade gestacional inferior a 35 semanas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Caracteriza&#231;&#227;o dos epis&#243;dios de interna&#231;&#227;o devido a ITRI</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabela 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">IC&#44; intervalo de confian&#231;a&#59; ITRI&#58; infec&#231;&#227;o do trato respirat&#243;rio inferior&#59; RTI&#58; raz&#227;o de taxa de incid&#234;ncia&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">O texto em negrito &#233; considerado significativo&#59; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Covari&#225;veis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">RTI bruta &#40;IC de 95&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">RTI ajustada &#40;IC de 95&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sexo feminino &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>masculino&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92 &#40;0&#44;55&#8208;1&#44;53&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;744&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;54&#8208;1&#44;57&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;773&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Idade gestacional &#40;semanas&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;84&#8208;1&#44;02&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;02<br>&#40;0&#44;87&#8208;1&#44;21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;795&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Displasia broncopulmonar &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;77<br>&#40;1&#44;67&#8208;4&#44;60&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#60; 0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;75<br>&#40;1&#44;53&#8208;4&#44;96&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiopatia cong&#234;nita &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;15<br>&#40;0&#44;49&#8208;2&#44;67&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;747&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;38&#8208;2&#44;26&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;864&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tabagismo<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">a</span></a> &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;55<br>&#40;0&#44;80&#8208;8&#44;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;115&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;36<br>&#40;0&#44;38&#8208;4&#44;89&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;637&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Peso ao nascer &#40;g&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;00&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;167&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;99<br>&#40;0&#44;99&#8208;1&#44;00&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;643&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ades&#227;o ao tratamento<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">b</span></a> &#40;percentual&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;371&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;290&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">M&#227;e com primeiro grau completo &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>sim&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;11<br>&#40;1&#44;04&#8208;4&#44;28&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;039&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;84<br>&#40;0&#44;85&#8208;3&#44;99&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;123&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520457.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0025"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0025">O &#8220;tabagismo&#8221; &#233; uma combina&#231;&#227;o das vari&#225;veis tabagismo em casa e tabagismo durante a gravidez&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0030"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Ades&#227;o&#58; percentual &#40;&#37;&#41; de doses recebidas em compara&#231;&#227;o com as esperadas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Fatores de risco de interna&#231;&#245;es por ITRI</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Tabela 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">MedDRA&#44; Dicion&#225;rio M&#233;dico para Atividades Regulat&#243;rias&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleBold">Eventos adversos graves</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Infec&#231;&#245;es e infesta&#231;&#245;es</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Bronquiolite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28 &#40;6&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleBold">Eventos adversos n&#227;o graves</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Dist&#250;rbios gastrointestinais</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Diarreia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">52 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Dist&#250;rbios gerais</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Pirexia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">49 &#40;10&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Infec&#231;&#245;es e infesta&#231;&#245;es</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Bronquiolite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">71 &#40;15&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Otite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Infec&#231;&#227;o do trato respirat&#243;rio superior&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">242 &#40;52&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Doen&#231;as respirat&#243;rias&#44; tor&#225;cicas e do mediastino</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Broncoespasmo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">73 &#40;15&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="char" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Doen&#231;as da pele e do tecido subcut&#226;neo</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Dermatite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Erup&#231;&#227;o cut&#226;nea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520460.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0035"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0035">Os indiv&#237;duos podem ter apresentado mais de um evento adverso &#40;n&#237;vel de termo preferencial do MedDRA&#41;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Eventos adversos graves e n&#227;o graves mais comuns &#40;&#8805; 5&#37; dos indiv&#237;duos&#41;<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:30 [
            0 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010&#58; a systematic analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "E&#46;A&#46; Sim&#245;es"
                            2 => "I&#46; Rudan"
                            3 => "B&#46;D&#46; Gessner"
                            4 => "E&#46; Azziz-Baumgartner"
                            5 => "J&#46;S&#46; Zhang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(12)61901-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2013"
                        "volumen" => "381"
                        "paginaInicial" => "1380"
                        "paginaFinal" => "1390"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23369797"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children&#58; a systematic review and meta&#8208;analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "D&#46;J&#46; Nokes"
                            2 => "B&#46;D&#46; Gessner"
                            3 => "M&#46; Dherani"
                            4 => "S&#46;A&#46; Madhi"
                            5 => "R&#46;J&#46; Singleton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60206-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "375"
                        "paginaInicial" => "1545"
                        "paginaFinal" => "1555"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20399493"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A decade of respiratory syncytial virus epidemiology and prophylaxis&#58; translating evidence into everyday clinical practice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46;A&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Banerji"
                            3 => "K&#46;L&#46; Lanct&#244;t"
                            4 => "J&#46;M&#46; Langley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Can Respir J"
                        "fecha" => "2011"
                        "volumen" => "18"
                        "paginaInicial" => "e10"
                        "paginaFinal" => "e19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21499597"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review and meta&#8208;analysis of respiratory syncytial virus infection epidemiology in Latin America"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Bardach"
                            1 => "L&#46; Rey-Ares"
                            2 => "M&#46;L&#46; Cafferata"
                            3 => "G&#46; Cormick"
                            4 => "M&#46; Romano"
                            5 => "S&#46; Ruvinsky"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Med Virol"
                        "fecha" => "2014"
                        "volumen" => "24"
                        "paginaInicial" => "76"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24757727"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus&#58; clinical and epidemiological pattern in pediatric patients admitted to a children&#39;s hospital between 2000 and 2013"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;F&#46; Lucion"
                            1 => "V&#46; Juarez Mdel"
                            2 => "M&#46; Viegas"
                            3 => "V&#46; Castellano"
                            4 => "V&#46;S&#46; Romanin"
                            5 => "M&#46; Grobaporto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5546/aap.2014.397"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2014"
                        "volumen" => "112"
                        "paginaInicial" => "397"
                        "paginaFinal" => "404"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25192519"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk factors for severe respiratory syncytial virus lower respiratory tract infection"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Sommer"
                            1 => "B&#46; Resch"
                            2 => "E&#46;A&#46; Sim&#245;es"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2174/1874285801105010144"
                      "Revista" => array:6 [
                        "tituloSerie" => "Open Microbiol J"
                        "fecha" => "2011"
                        "volumen" => "5"
                        "paginaInicial" => "144"
                        "paginaFinal" => "154"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22262987"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A population&#8208;weighted&#44; condition&#8208;adjusted estimate of palivizumab efficacy in preventing RSV&#8208;related hospitalizations among US high&#8208;risk children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46;S&#46; Ambrose"
                            1 => "X&#46; Chen"
                            2 => "V&#46;R&#46; Kumar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4161/hv.32082"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hum Vaccin Immunother"
                        "fecha" => "2014"
                        "volumen" => "10"
                        "paginaInicial" => "2785"
                        "paginaFinal" => "2788"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25483483"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Palivizumab&#44; a humanized respiratory syncytial virus monoclonal antibody&#44; reduces hospitalization from respiratory syncytial virus infection in high&#8208;risk infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "The IMpact-RSV Study Group"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "1998"
                        "volumen" => "102"
                        "paginaInicial" => "531"
                        "paginaFinal" => "537"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9738173"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy&#44; 1998&#8211;2008"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;R&#46; Groothuis"
                            1 => "J&#46;P&#46; Fryzek"
                            2 => "D&#46; Makari"
                            3 => "D&#46; Steffey"
                            4 => "W&#46;J&#46; Martone"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2147/CLEP.S17189"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Epidemiol"
                        "fecha" => "2011"
                        "volumen" => "3"
                        "paginaInicial" => "245"
                        "paginaFinal" => "250"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22003308"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants&#58; a prospective birth cohort study in Brazil"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Arruda"
                            1 => "M&#46;H&#46; Jones"
                            2 => "F&#46; Escremim de Paula"
                            3 => "D&#46; Chong"
                            4 => "G&#46; Bugarin"
                            5 => "G&#46; Notario"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/INF.0000000000000349"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Infect Dis J"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "997"
                        "paginaFinal" => "1003"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25361184"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An evaluation of the emerging interventions against respiratory syncytial virus &#40;RSV&#41;&#8208;associated acute lower respiratory infections in children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "V&#46;R&#46; Verma"
                            2 => "E&#46; Theodoratou"
                            3 => "L&#46; Zgaga"
                            4 => "T&#46; Huda"
                            5 => "E&#46;A&#46; Sim&#245;es"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/1471-2458-11-S3-S30"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Public Health"
                        "fecha" => "2011"
                        "volumen" => "11"
                        "paginaInicial" => "S30"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21501449"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and effectiveness of palivizumab in children at high risk of serious disease due to respiratory syncytial virus infection&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Wegzyn"
                            1 => "L&#46;K&#46; Toh"
                            2 => "G&#46; Notario"
                            3 => "S&#46; Biguenet"
                            4 => "K&#46; Unnebrink"
                            5 => "C&#46; Park"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s40121-014-0046-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Infect Dis Ther"
                        "fecha" => "2014"
                        "volumen" => "3"
                        "paginaInicial" => "133"
                        "paginaFinal" => "158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25297809"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;F&#46; Feltes"
                            1 => "A&#46;K&#46; Cabalka"
                            2 => "H&#46;C&#46; Meissner"
                            3 => "F&#46;M&#46; Piazza"
                            4 => "D&#46;A&#46; Carlin"
                            5 => "F&#46;H&#46; Top Jr&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2003"
                        "volumen" => "143"
                        "paginaInicial" => "532"
                        "paginaFinal" => "540"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14571236"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The epidemiology and clinical characteristics of respiratory syncytial virus infection in children at a public pediatric referral hospital in Mexico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;P&#46; Rodr&#237;guez-Auad"
                            1 => "M&#46; Nava-Fr&#237;as"
                            2 => "J&#46; Casasola-Flores"
                            3 => "K&#46;M&#46; Johnson"
                            4 => "A&#46; Nava-Ruiz"
                            5 => "V&#46; P&#233;rez-Robles"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijid.2012.03.001"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Infect Dis"
                        "fecha" => "2012"
                        "volumen" => "16"
                        "paginaInicial" => "e508"
                        "paginaFinal" => "e513"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22525227"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus infection in Guatemala&#44; 2007&#8211;2012"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;P&#46; McCracken"
                            1 => "M&#46;M&#46; Prill"
                            2 => "W&#46; Arvelo"
                            3 => "K&#46;A&#46; Lindblade"
                            4 => "M&#46;R&#46; L&#243;pez"
                            5 => "A&#46; Estevez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/infdis/jit517"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Infect Dis"
                        "fecha" => "2013"
                        "volumen" => "208"
                        "paginaInicial" => "S197"
                        "paginaFinal" => "S206"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24265479"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidence and clinical characteristics of the infection by the respiratory syncytial virus in children admitted in Santa Casa de S&#227;o Paulo Hospital"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Pecchini"
                            1 => "E&#46;N&#46; Berezin"
                            2 => "M&#46;C&#46; Fel&#237;cio"
                            3 => "S&#46;D&#46; Passos"
                            4 => "M&#46;C&#46; Souza"
                            5 => "L&#46;R&#46; Lima"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Braz J Infect Dis"
                        "fecha" => "2008"
                        "volumen" => "12"
                        "paginaInicial" => "476"
                        "paginaFinal" => "479"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19287833"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile &#40;1989 to 2000&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46;F&#46; Avenda&#241;o"
                            1 => "M&#46;A&#46; Palomino"
                            2 => "C&#46; Larra&#241;aga"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Microbiol"
                        "fecha" => "2003"
                        "volumen" => "41"
                        "paginaInicial" => "4879"
                        "paginaFinal" => "4882"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14532249"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "French Pediatricians&#8217; Group of Sunagis Patients&#8217; Name&#8208;Based Programs&#46; Incidence of respiratory syncytial virus&#8208;related hospitalizations in high&#8208;risk children&#58; follow&#8208;up of a national cohort of infants treated with Palivizumab as RSV prophylaxis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "T&#46; Lacaze-Masmonteil"
                            1 => "J&#46;C&#46; Roz&#233;"
                            2 => "B&#46; Fauroux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ppul.10175"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Pulmonol"
                        "fecha" => "2002"
                        "volumen" => "34"
                        "paginaInicial" => "181"
                        "paginaFinal" => "188"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12203846"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bronchopulmonary dysplasia&#58; incidence&#44; risk factors and resource utilization in a population of South American very low birth weight infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Tapia"
                            1 => "D&#46; Agost"
                            2 => "A&#46; Alegria"
                            3 => "J&#46; Standen"
                            4 => "M&#46; Escobar"
                            5 => "C&#46; Grandi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Pediatr &#40;Rio J&#41;"
                        "fecha" => "2006"
                        "volumen" => "82"
                        "paginaInicial" => "15"
                        "paginaFinal" => "20"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus and recurrent wheeze in healthy preterm infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;O&#46; Blanken"
                            1 => "M&#46;M&#46; Rovers"
                            2 => "J&#46;M&#46; Molenaar"
                            3 => "P&#46;L&#46; Winkler-Seinstra"
                            4 => "A&#46; Meijer"
                            5 => "J&#46;L&#46; Kimpen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1211917"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "1791"
                        "paginaFinal" => "1799"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23656644"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of hospitalization due to respiratory syncytial virus&#58; results from the Palivizumab Outcomes Registry"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Frogel"
                            1 => "C&#46; Nerwen"
                            2 => "A&#46; Cohen"
                            3 => "P&#46; VanVeldhuisen"
                            4 => "M&#46; Harrington"
                            5 => "M&#46; Boron"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/jp.2008.28"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Perinatol"
                        "fecha" => "2008"
                        "volumen" => "28"
                        "paginaInicial" => "511"
                        "paginaFinal" => "517"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18368063"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "CARESS Investigators&#46; A comparative study of respiratory syncytial virus &#40;RSV&#41; prophylaxis in premature infants within the Canadian Registry of Palivizumab &#40;CARESS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Li"
                            3 => "K&#46;L&#46; Lanct&#244;t"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10096-012-1617-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Microbiol Infect Dis"
                        "fecha" => "2012"
                        "volumen" => "31"
                        "paginaInicial" => "2703"
                        "paginaFinal" => "2711"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22546928"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of a respiratory disease prevention program in high&#8208;risk preterm infants&#58; a prospective&#44; multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Bauer"
                            1 => "L&#46; Bossi"
                            2 => "M&#46; Santoalla"
                            3 => "S&#46; Rodr&#237;guez"
                            4 => "D&#46; Fari&#241;a"
                            5 => "A&#46;M&#46; Speranza"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/S0325-00752009000200004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2009"
                        "volumen" => "107"
                        "paginaInicial" => "111"
                        "paginaFinal" => "118"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19452082"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory&#8208;related hospitalizations following prophylaxis in the Canadian registry for palivizumab &#40;2005&#8211;2012&#41; compared to other international registries"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Li"
                            3 => "T&#46; Harimoto"
                            4 => "K&#46;L&#46; Lanct&#244;t"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2013/917068"
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Dev Immunol"
                        "fecha" => "2013"
                        "volumen" => "2013"
                        "paginaInicial" => "917068"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23861694"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "E&#46;A&#46; Simoes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2003"
                        "volumen" => "143"
                        "paginaInicial" => "S118"
                        "paginaFinal" => "S126"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14615710"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus &#40;RSV&#41; in infants hospitalized for acute lower respiratory tract disease&#58; incidence and associated risks"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;G&#46; Riccetto"
                            1 => "J&#46;D&#46; Ribeiro"
                            2 => "M&#46;T&#46; Silva"
                            3 => "R&#46;S&#46; Almeida"
                            4 => "C&#46;W&#46; Arns"
                            5 => "E&#46;C&#46; Baracat"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Braz J Infect Dis"
                        "fecha" => "2006"
                        "volumen" => "10"
                        "paginaInicial" => "357"
                        "paginaFinal" => "361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17293926"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Infecci&#243;n por virus sincicial respiratorio en poblaciones vulnerables&#58; riesgo biol&#243;gico contra riesgo social"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46; Bauer"
                            1 => "V&#46; Dussel"
                            2 => "D&#46; Fari&#241;a"
                            3 => "S&#46; Rodr&#237;guez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2005"
                        "volumen" => "103"
                        "paginaInicial" => "198"
                        "paginaFinal" => "204"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of palivizumab in preterm infants 29 to 32 weeks&#8217; gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;R&#46; Groothuis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10096-003-0961-z"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Microbiol Infect Dis"
                        "fecha" => "2003"
                        "volumen" => "22"
                        "paginaInicial" => "414"
                        "paginaFinal" => "417"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12827537"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory infections in children up to two years of age on prophylaxis with palivizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46;I&#46; Monteiro"
                            1 => "N&#46;C&#46; Bellei"
                            2 => "A&#46;R&#46; Sousa"
                            3 => "A&#46;M&#46; dos Santos"
                            4 => "L&#46;Y&#46; Weckx"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Paul Pediatr"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "152"
                        "paginaFinal" => "158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25119744"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus disease in preterm infants in the U&#46;S&#46; born at 32&#8211;35 weeks gestation not receiving immunoprophylaxis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;S&#46; Ambrose"
                            1 => "E&#46;J&#46; Anderson"
                            2 => "E&#46;A&#46; Sim&#245;es"
                            3 => "X&#46; Wu"
                            4 => "H&#46; Elhefni"
                            5 => "C&#46;L&#46; Park"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/INF.0000000000000219"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Infect Dis J"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "576"
                        "paginaFinal" => "582"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24622396"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack301132"
        "titulo" => "Agradecimentos"
        "texto" => "<p id="par0155" class="elsevierStylePara elsevierViewall">Ao Dr&#46; Guillermo de Jesus Ruelas Orozco&#44; &#224; Dra&#46; Margarita Morales Marquez&#44; Dra&#46; Carolina Salazar e Dra&#46; Adriana Castro e &#224; Sra&#46; Mariana Jacqueline Mart&#237;nez Mu&#241;oz por sua colabora&#231;&#227;o neste estudo&#46; E &#224; Sra&#46; Milene Fernandes &#40;Eurotrials&#44; Scientific Consultants&#41;&#44; que ajudou a redigir este trabalho&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300277/v1_201709220128/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "16682"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Artigos originais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/22555536/0000009300000005/v1_201709220128/S2255553617300277/v1_201709220128/pt/main.pdf?idApp=UINPBA000049&text.app=https://jped.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300277?idApp=UINPBA000049"
]
Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

Artigo Original
One‐year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America
Estudo observacional de um ano da profilaxia com palivizumabe em neonatos com risco para infecção por vírus sincicial respiratório na América Latina
Leandro Martin Castilloa, Gabriela Bugarina,
Autor para correspondência
gabriela.bugarin@abbvie.com

Autor para correspondência.
, Juan Carlos Ariasb, Jairo Israel Barajas Rangelc, Maria Elina Serrad, Nestor Vaind,e
a AbbVie Inc., Buenos Aires, Argentina
b Casa Madre Canguro Alfa S.A., Cali, Colômbia
c Hospital General Regional de León, León, Guanajuato, México
d Fundación para la Salud Materno Infantil (Fundasamin), Buenos Aires, Argentina
e Sanatorio de la Trinidad Palermo, Buenos Aires, Argentina
Lido
2823
Vezes
que se leu este artigo
1329
Total PDF
1494
Total HTML
Compartilhar estatísticas
 array:25 [
  "pii" => "S2255553617300277"
  "issn" => "22555536"
  "doi" => "10.1016/j.jpedp.2017.02.014"
  "estado" => "S300"
  "fechaPublicacion" => "2017-09-01"
  "aid" => "477"
  "copyright" => "Sociedade Brasileira de Pediatria"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:467-74"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 971
    "formatos" => array:3 [
      "EPUB" => 119
      "HTML" => 576
      "PDF" => 276
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S0021755717301213"
      "issn" => "00217557"
      "doi" => "10.1016/j.jped.2016.11.006"
      "estado" => "S300"
      "fechaPublicacion" => "2017-09-01"
      "aid" => "477"
      "copyright" => "Sociedade Brasileira de Pediatria"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:467-74"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 841
        "formatos" => array:3 [
          "EPUB" => 98
          "HTML" => 504
          "PDF" => 239
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
        "titulo" => "One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "pt"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "467"
            "paginaFinal" => "474"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "pt" => array:1 [
            "titulo" => "Estudo observacional de um ano da profilaxia com palivizumabe em neonatos com risco para infec&#231;&#227;o por v&#237;rus sincicial respirat&#243;rio na Am&#233;rica Latina"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "pt" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Leandro Martin Castillo, Gabriela Bugarin, Juan Carlos Arias, Jairo Israel Barajas Rangel, Maria Elina Serra, Nestor Vain"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Leandro Martin"
                "apellidos" => "Castillo"
              ]
              1 => array:2 [
                "nombre" => "Gabriela"
                "apellidos" => "Bugarin"
              ]
              2 => array:2 [
                "nombre" => "Juan Carlos"
                "apellidos" => "Arias"
              ]
              3 => array:2 [
                "nombre" => "Jairo Israel"
                "apellidos" => "Barajas Rangel"
              ]
              4 => array:2 [
                "nombre" => "Maria Elina"
                "apellidos" => "Serra"
              ]
              5 => array:2 [
                "nombre" => "Nestor"
                "apellidos" => "Vain"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2255553617300277"
          "doi" => "10.1016/j.jpedp.2017.02.014"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300277?idApp=UINPBA000049"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717301213?idApp=UINPBA000049"
      "url" => "/00217557/0000009300000005/v1_201709220054/S0021755717301213/v1_201709220054/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S2255553617300800"
    "issn" => "22555536"
    "doi" => "10.1016/j.jpedp.2017.07.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-09-01"
    "aid" => "513"
    "copyright" => "Sociedade Brasileira de Pediatria"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:475-81"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 961
      "formatos" => array:3 [
        "EPUB" => 79
        "HTML" => 636
        "PDF" => 246
      ]
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
      "titulo" => "Influence of maternity leave on exclusive breastfeeding"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "475"
          "paginaFinal" => "481"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Influ&#234;ncia da licen&#231;a&#8208;maternidade sobre a amamenta&#231;&#227;o exclusiva"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Fernanda R&#46; Monteiro, Gabriela dos S&#46; Buccini, S&#244;nia I&#46; Ven&#226;ncio, Teresa H&#46;M&#46; da Costa"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Fernanda R&#46;"
              "apellidos" => "Monteiro"
            ]
            1 => array:2 [
              "nombre" => "Gabriela dos S&#46;"
              "apellidos" => "Buccini"
            ]
            2 => array:2 [
              "nombre" => "S&#244;nia I&#46;"
              "apellidos" => "Ven&#226;ncio"
            ]
            3 => array:2 [
              "nombre" => "Teresa H&#46;M&#46; da"
              "apellidos" => "Costa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0021755717306423"
        "doi" => "10.1016/j.jped.2016.11.016"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717306423?idApp=UINPBA000049"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300800?idApp=UINPBA000049"
    "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300800/v1_201709220128/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2255553617300253"
    "issn" => "22555536"
    "doi" => "10.1016/j.jpedp.2017.02.012"
    "estado" => "S300"
    "fechaPublicacion" => "2017-09-01"
    "aid" => "473"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "J Pediatr &#40;Rio J&#41;. 2017;93:460-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1602
      "formatos" => array:3 [
        "EPUB" => 104
        "HTML" => 1241
        "PDF" => 257
      ]
    ]
    "pt" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
      "titulo" => "Early amplitude&#8208;integrated electroencephalography for monitoring neonates at high risk for brain injury"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "460"
          "paginaFinal" => "466"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Eletroencefalograma de amplitude integrada precoce no monitoramento de neonatos com risco elevado de les&#227;o cerebral"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1601
              "Ancho" => 1619
              "Tamanyo" => 111796
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o da atividade de fundo nos primeiros tr&#234;s dias de vida em neonatos prematuros com resultado inicial bom e ruim&#46;</p> <p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">DLVP&#44; padr&#227;o descont&#237;nuo de baixa volagem&#59; DHVP&#44; padr&#227;o descont&#237;nuo de alta voltagem&#59; CVP&#44; padr&#227;o de voltagem cont&#237;nua&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Gabriel Fernando Todeschi Variane, Maur&#237;cio Magalh&#227;es, Renato Gasperine, Heitor Castelo Branco Rodrigues Alves, Thiago Luiz Pereira Donoso Scoppetta, Rodrigo de Jesus Gon&#231;alves Figueredo, Francisco Paulo Martins Rodrigues, Alexandre Netto, Marcelo Jenne Mimica, Clery Bernardi Gallacci"
          "autores" => array:10 [
            0 => array:2 [
              "nombre" => "Gabriel Fernando Todeschi"
              "apellidos" => "Variane"
            ]
            1 => array:2 [
              "nombre" => "Maur&#237;cio"
              "apellidos" => "Magalh&#227;es"
            ]
            2 => array:2 [
              "nombre" => "Renato"
              "apellidos" => "Gasperine"
            ]
            3 => array:2 [
              "nombre" => "Heitor Castelo Branco Rodrigues"
              "apellidos" => "Alves"
            ]
            4 => array:2 [
              "nombre" => "Thiago Luiz Pereira Donoso"
              "apellidos" => "Scoppetta"
            ]
            5 => array:2 [
              "nombre" => "Rodrigo de Jesus Gon&#231;alves"
              "apellidos" => "Figueredo"
            ]
            6 => array:2 [
              "nombre" => "Francisco Paulo Martins"
              "apellidos" => "Rodrigues"
            ]
            7 => array:2 [
              "nombre" => "Alexandre"
              "apellidos" => "Netto"
            ]
            8 => array:2 [
              "nombre" => "Marcelo Jenne"
              "apellidos" => "Mimica"
            ]
            9 => array:2 [
              "nombre" => "Clery Bernardi"
              "apellidos" => "Gallacci"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0021755716302595"
        "doi" => "10.1016/j.jped.2016.12.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755716302595?idApp=UINPBA000049"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300253?idApp=UINPBA000049"
    "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300253/v1_201709220128/pt/main.assets"
  ]
  "pt" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>"
    "titulo" => "One&#8208;year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "467"
        "paginaFinal" => "474"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Leandro Martin Castillo, Gabriela Bugarin, Juan Carlos Arias, Jairo Israel Barajas Rangel, Maria Elina Serra, Nestor Vain"
        "autores" => array:6 [
          0 => array:3 [
            "nombre" => "Leandro Martin"
            "apellidos" => "Castillo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Gabriela"
            "apellidos" => "Bugarin"
            "email" => array:1 [
              0 => "gabriela&#46;bugarin&#64;abbvie&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Juan Carlos"
            "apellidos" => "Arias"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Jairo Israel Barajas"
            "apellidos" => "Rangel"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Maria Elina"
            "apellidos" => "Serra"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Nestor"
            "apellidos" => "Vain"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "AbbVie Inc&#46;&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Casa Madre Canguro Alfa S&#46;A&#46;&#44; Cali&#44; Col&#244;mbia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Hospital General Regional de Le&#243;n&#44; Le&#243;n&#44; Guanajuato&#44; M&#233;xico"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Fundaci&#243;n para la Salud Materno Infantil &#40;Fundasamin&#41;&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Sanatorio de la Trinidad Palermo&#44; Buenos Aires&#44; Argentina"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Estudo observacional de um ano da profilaxia com palivizumabe em neonatos com risco para infec&#231;&#227;o por v&#237;rus sincicial respirat&#243;rio na Am&#233;rica Latina"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introdu&#231;&#227;o</span><p id="par0005" class="elsevierStylePara elsevierViewall">As infec&#231;&#245;es do trato respirat&#243;rio inferior &#40;ITRI&#41; s&#227;o a principal causa de doen&#231;as agudas e mortalidade em neonatos e crian&#231;as<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>5 anos&#44; representam aproximadamente 1&#44;4 milh&#227;o de &#243;bitos em todo o mundo em 2010&#46;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">1</span></a> O v&#237;rus sincicial respirat&#243;rio &#40;VSR&#41; &#233; a etiologia mais frequente de doen&#231;as respirat&#243;rias graves&#44; como a bronquiolite e&#47;ou pneumonia&#46;<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">2&#44;3</span></a> Uma metan&#225;lise estimou que pelo menos 33&#44;8 milh&#245;es de epis&#243;dios de ITRI e 66&#46;000 a 199&#46;000 &#243;bitos em crian&#231;as<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>5 anos foram causados por uma infec&#231;&#227;o por VSR em 2005&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">2</span></a> Praticamente 99&#37; dos &#243;bitos por VSR ocorreram em pa&#237;ses em desenvolvimento&#44; nos quais a incid&#234;ncia de ITRI associada ao VSR parece ser mais do que o dobro daquela observada em pa&#237;ses industrializados&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Na Am&#233;rica Latina&#44; uma metan&#225;lise recente estimou preval&#234;ncia de 41&#44;5&#37; &#40;IC de 95&#37;&#44; 32&#44;0&#8208;41&#44;4&#41; de VSR em neonatos de 0&#8208;11 meses com ITRI e estimou que o VSR foi respons&#225;vel por 36&#44;5&#37; &#40;IC de 95&#37;&#44; 28&#44;5&#8208;44&#44;9&#41; das interna&#231;&#245;es em hospitais devido a ITRI entre neonatos de 0 a 11 meses&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">4</span></a> Ademais&#44; uma poss&#237;vel coorte epidemiol&#243;gica de pacientes com<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>18 anos internados devido a ITRIs de 2000 a 2013 em Buenos Aires registrou uma taxa de fatalidade associada ao VSR de 1&#44;9&#37; &#40;74 &#243;bitos&#47;3&#46;888 casos&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">5</span></a> Apesar de essas estimativas indicarem uma urg&#234;ncia das interven&#231;&#245;es relacionadas &#224; sa&#250;de&#44; s&#227;o necess&#225;rios mais estudos para quantificar a carga de doen&#231;a devido ao VSR e os fatores de risco associados &#224;s interna&#231;&#245;es por ITRI em pa&#237;ses da Am&#233;rica Latina&#46;<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">2&#44;4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">V&#225;rios fatores sociais e relacionados ao paciente foram associados ao aumento do risco de infec&#231;&#227;o por VSR&#44; a saber&#44; idade<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>6 meses no in&#237;cio da esta&#231;&#227;o de incid&#234;ncia do VSR&#44; sexo masculino&#44; nascimento m&#250;ltiplo&#44; aglomera&#231;&#227;o em casa&#44; baixa situa&#231;&#227;o socioecon&#244;mica e escolaridade dos pais&#44; frequ&#234;ncia em creche&#44; exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em ambientes fechados e amamenta&#231;&#227;o reduzida&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">6&#44;7</span></a> Al&#233;m disso&#44; alguns quadros cl&#237;nicos est&#227;o associados a doen&#231;as graves e &#224; interna&#231;&#227;o por VSR&#44; inclusive prematuridade &#40;neonatos nascidos com &#8804; 35 semanas de idade gestacional&#41;&#44; displasia broncopulmonar &#40;DBP&#41; e cardiopatia cong&#234;nita hemodinamicamente significativa &#40;CCHS&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">3&#44;8&#8211;10</span></a> Contudo&#44; a import&#226;ncia relativa desses fatores de risco poder&#225; ser diferente na Am&#233;rica Latina&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">O palivizumabe &#40;Synagis&#174;&#59; AbbVie Inc&#44; IL&#44; EUA&#41; &#233; um anticorpo monoclonal humanizado aprovado para a preven&#231;&#227;o de doen&#231;as graves por VSR em beb&#234;s prematuros e jovens crian&#231;as com DBP ou CCHS&#46;<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">11</span></a> Sua seguran&#231;a e efic&#225;cia foram avaliadas em estudos controlados randomizados&#44; testes abertos n&#227;o comparativos e diversos estudos observacionais&#46;<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">12</span></a> Taxas mais baixas de interna&#231;&#245;es por VSR e complica&#231;&#245;es cl&#237;nicas foram relatadas em crian&#231;as que receberam a profilaxia com palivizumabe&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;12&#44;13</span></a> Entretanto&#44; existe uma escassez de dados sobre o uso e a efic&#225;cia do palivizumabe em pa&#237;ses em desenvolvimento&#44; nos quais as taxas de infec&#231;&#227;o por VSR s&#227;o mais elevadas&#44; especificamente em pa&#237;ses da Am&#233;rica Latina&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">12&#44;14&#8211;17</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Este estudo visa a descrever o uso do palivizumabe em neonatos de alto risco e estimar a frequ&#234;ncia de interna&#231;&#227;o por VSR entre neonatos e jovens crian&#231;as tratadas com palivizumabe em pa&#237;ses da Am&#233;rica Latina no per&#237;odo de um ano de acompanhamento ap&#243;s a primeira dose&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">M&#233;todos</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Modelo do estudo</span><p id="par0030" class="elsevierStylePara elsevierViewall">Este foi um estudo multic&#234;ntrico prospectivo e observacional em uma coorte de neonatos em risco devido a infec&#231;&#227;o grave por VSR que receberam palivizumabe durante a circula&#231;&#227;o local de VSR e nos termos da autoriza&#231;&#227;o de venda a respeito de dosagem&#44; popula&#231;&#227;o e indica&#231;&#227;o&#46; O estudo foi feito em 24 locais de sete pa&#237;ses da Am&#233;rica Latina &#40;Argentina&#44; Chile&#44; Col&#244;mbia&#44; Equador&#44; M&#233;xico&#44; Peru e Uruguai&#41;&#46; O recrutamento de indiv&#237;duos come&#231;ou em 19 de fevereiro de 2011 e foi conclu&#237;do em 6 de setembro de 2012&#59; cada indiv&#237;duo foi monitorado por 12 meses&#44; com visitas mensais no per&#237;odo de administra&#231;&#227;o de palivizumabe e&#44; depois&#44; com liga&#231;&#245;es mensais&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Crit&#233;rios de elegibilidade</span><p id="par0035" class="elsevierStylePara elsevierViewall">Em cada local do estudo&#44; beb&#234;s prematuros &#40;nascidos com &#8804; 35 semanas de idade gestacional&#41; ou jovens crian&#231;as com hist&#243;rico de DBP ou CCHS que receberam a primeira dose de palivizumabe nas semanas anteriores &#224; avalia&#231;&#227;o dos crit&#233;rios de inclus&#227;o eram eleg&#237;veis para participar&#46; Crian&#231;as exclu&#237;das da administra&#231;&#227;o de palivizumabe segundo a pr&#225;tica local n&#227;o participaram&#46; Os pais ou respons&#225;veis legais dos neonatos e jovens crian&#231;as inclu&#237;dos forneceram um consentimento informado por escrito&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Acompanhamento e coleta de dados</span><p id="par0040" class="elsevierStylePara elsevierViewall">Os indiv&#237;duos inscritos foram acompanhados por um ano ap&#243;s sua primeira dose de palivizumabe&#46; Dados epidemiol&#243;gicos e cl&#237;nicos&#44; informa&#231;&#245;es sobre a ades&#227;o de pacientes&#44; interna&#231;&#245;es e dados de seguran&#231;a foram coletados mensalmente de acordo com a pr&#225;tica cl&#237;nica de rotina&#44; por meio de avalia&#231;&#245;es no consult&#243;rio durante os quatro primeiros meses&#46; Ap&#243;s os quatro primeiros meses&#44; ocorreram visitas de monitoramento de seis e 12 meses e liga&#231;&#245;es de acompanhamento nos meses 5&#44; 7&#44; 8&#44; 9&#44; 10 e 11 ap&#243;s a inclus&#227;o do indiv&#237;duo no estudo&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">O hist&#243;rico de sa&#250;de de cada paciente e a exposi&#231;&#227;o a fatores de risco ambiental foram coletados e foi feito um exame f&#237;sico em cada visita ao consult&#243;rio para o estudo&#46; Eventos adversos e interna&#231;&#245;es ocorridas desde a visita anterior tamb&#233;m foram registrados&#46; A ITRI foi definida como pneumonia&#44; bronquiolite ou pieira de acordo com o diagn&#243;stico cl&#237;nico&#46; Foram coletadas amostras nasais e faringianas para o teste de VSR apenas quando recomendado pelas diretrizes cl&#237;nicas locais e&#47;ou mediante decis&#227;o do m&#233;dico&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">As crian&#231;as podiam receber at&#233; cinco doses de palivizumabe&#44; de acordo com a prescri&#231;&#227;o do m&#233;dico&#46; A ades&#227;o dos pacientes ao tratamento foi calculada como o n&#250;mero de doses de palivizumabe recebidas em compara&#231;&#227;o com o n&#250;mero esperado de doses&#46; O n&#250;mero esperado de doses para cada paciente foi estimado com base na sazonalidade e nas diretrizes atuais de cada pa&#237;s&#46; Foi feita uma an&#225;lise do intervalo entre doses &#40;nos casos em que a data de cada dose estava dispon&#237;vel&#41; e os intervalos de 30 &#40;&#177; 5&#41; dias foram considerados em conformidade&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">An&#225;lise de seguran&#231;a</span><p id="par0055" class="elsevierStylePara elsevierViewall">Os eventos adversos foram classificados com base na classifica&#231;&#227;o do sistema da vers&#227;o 16&#46;0 do Dicion&#225;rio M&#233;dico para Atividades Regulat&#243;rias&#46; Eventos adversos graves foram definidos como qualquer evento adverso que tenha resultado em &#243;bito&#44; situa&#231;&#227;o de risco de vida&#44; interna&#231;&#227;o do paciente&#44; defici&#234;ncia ou incapacidade persistente ou significativa ou em outros eventos clinicamente relevantes&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">An&#225;lise estat&#237;stica</span><p id="par0060" class="elsevierStylePara elsevierViewall">Foi estimado um tamanho m&#237;nimo de amostra de 400 pacientes com base no poss&#237;vel n&#250;mero de pacientes que recebiam palivizumabe em cada pa&#237;s para permitir a estimativa da propor&#231;&#227;o de ITRIs com intervalo de confian&#231;a &#40;IC&#41; de 95&#37;&#44; com precis&#227;o estimada de 3&#37;&#46; Toda a an&#225;lise de dados foi feita com o Stata &#40;StataCorp&#46; 2007&#46;&#160;Stata Software estat&#237;stico&#58; vers&#227;o 10&#46; TX&#44; EUA&#41;&#46; As frequ&#234;ncias e percentuais de vari&#225;veis categ&#243;ricas e as medidas da posi&#231;&#227;o central e da dispers&#227;o de vari&#225;veis quantitativas foram usadas para descrever as caracter&#237;sticas dos indiv&#237;duos da amostra&#44; o uso de palivizumabe e os eventos adversos mais comuns&#46; Foi estimado um IC de 95&#37; para as propor&#231;&#245;es ou taxas de incid&#234;ncia dos resultados relevantes&#46; Foram usados modelos lineares generalizados para estimar as taxas anuais de interna&#231;&#227;o por ITRI&#46; Os modelos de regress&#227;o de Poisson foram aplicados para identificar os fatores de risco das interna&#231;&#245;es por ITRI e as caracter&#237;sticas b&#225;sicas como idade&#44; sexo&#44; peso ao nascer e comorbidades foram inclu&#237;das como covari&#225;veis&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Este estudo foi feito de acordo com a Declara&#231;&#227;o de Helsinque&#46; O protocolo foi aprovado por comit&#234;s &#233;ticos institucionais independentes antes do in&#237;cio e segundo a legisla&#231;&#227;o nacional&#46; Foi obtido o consentimento informado por escrito de no m&#237;nimo um pai ou respons&#225;vel legal de todos os pacientes&#46;</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Resultados</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Caracter&#237;sticas da amostra</span><p id="par0070" class="elsevierStylePara elsevierViewall">Foram inscritos 464 neonatos e jovens crian&#231;as de 24 locais de sete pa&#237;ses da Am&#233;rica Latina&#44; dos quais seis foram exclu&#237;das devido &#224; aus&#234;ncia de visitas de acompanhamento adicionais &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>4&#41;&#44; consentimento informado inv&#225;lido &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#41; e administra&#231;&#227;o de palivizumabe na esta&#231;&#227;o anterior &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#41;&#46; Assim&#44; 458 neonatos e jovens crian&#231;as foram inclu&#237;dos e 397 &#40;86&#44;7&#37;&#41; completaram um ano de acompanhamento&#46; Entre os 61 neonatos e jovens crian&#231;as que n&#227;o conclu&#237;ram o acompanhamento&#44; 43 &#40;70&#44;5&#37;&#41; deixaram de ser acompanhados&#44; seis &#40;9&#44;8&#37;&#41; retiraram o consentimento do estudo&#44; tr&#234;s &#40;4&#44;9&#37;&#41; faleceram por motivos n&#227;o relacionados a doen&#231;as respirat&#243;rias e nove &#40;29&#44;4&#37;&#41; n&#227;o conclu&#237;ram o estudo por outros motivos&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Os dados demogr&#225;ficos dos neonatos e das jovens crian&#231;as inclu&#237;dos s&#227;o apresentados na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#59; 52&#37; dos pacientes eram do sexo masculino&#46; O peso m&#233;dio ao nascer era de 1&#46;345<span class="elsevierStyleHsp" style=""></span>g &#40;desvio padr&#227;o &#91;DP&#93; 460&#41; e a idade gestacional mediana era de 31 semanas &#40;varia&#231;&#227;o de 23&#8208;39 semanas&#41;&#46; Quase todos os pacientes do estudo &#40;98&#44;2&#37;&#41; foram prematuros&#59; 29&#44;2&#37; dos pacientes apresentavam DBP e 10&#44;1&#37;&#44; CCHS&#46; Al&#233;m disso&#44; a prematuridade com DBP e&#47;ou CCHS foi observada em 33&#44;4&#37; dos pacientes&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Uso e ades&#227;o do paciente ao palivizumabe</span><p id="par0080" class="elsevierStylePara elsevierViewall">O motivo mais frequente da indica&#231;&#227;o de palivizumabe foi a prematuridade &#40;por si mesma ou em conjunto com outras indica&#231;&#245;es&#41; &#40;98&#44;0&#37;&#41;&#46; O n&#250;mero total de doses administradas foi de 1&#46;744 em 458 pacientes&#44; corresponde a 3&#44;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;3 doses por paciente em m&#233;dia&#46; De maneira geral&#44; os pacientes receberam 83&#44;7&#37; &#40;IC de 95&#37;&#44; 80&#44;8&#8208;86&#44;5&#41; de suas doses esperadas&#44; com base na sazonalidade e nas atuais diretrizes de cada pa&#237;s&#44; e 78&#44;4&#37; dos 1&#46;249 intervalos entre doses foram classificados como aderentes &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#41;&#46; O tempo m&#233;dio entre o in&#237;cio da profilaxia com palivizumabe e o desenvolvimento de ITRI devido ao VSR foi de 75&#44;7 dias&#44; com mediana de 44 dias&#46;</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Interna&#231;&#245;es devido &#224; ITRI</span><p id="par0085" class="elsevierStylePara elsevierViewall">Ocorreram 61 epis&#243;dios de ITRI que exigiram interna&#231;&#227;o em 52 crian&#231;as &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">tabela 2</a>&#41;&#46; A taxa de interna&#231;&#227;o devida a ITRI foi de 14&#44;6 em cada 100 pacientes&#8208;anos &#40;IC de 95&#37;&#44; 10&#44;5&#8208;18&#44;6&#41;&#46; A infec&#231;&#227;o por VSR foi confirmada em 12 epis&#243;dios em 12 neonatos e a taxa de interna&#231;&#227;o associada ao VSR foi de 2&#44;9 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 1&#44;3&#8208;4&#44;5&#41;&#46; Nenhuma das interna&#231;&#245;es por VSR exigiu apoio respirat&#243;rio&#46; Dos 12 casos de interna&#231;&#227;o associada ao VSR&#44; todos eram beb&#234;s prematuros e dez apresentaram outro fator de risco&#58; nove eram pacientes com DBP e um apresentava CCHS&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Foram feitas an&#225;lises univariadas e multivariadas para identificar os fatores de risco da interna&#231;&#227;o por LRTI &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">tabela 3</a>&#41;&#46; Na an&#225;lise univariada&#44; um n&#237;vel mais baixo de escolaridade materna e a DBP provaram aumentar o risco de interna&#231;&#227;o por ITRI em uma popula&#231;&#227;o que recebeu a profilaxia com palivizumabe&#46; Na an&#225;lise do modelo multivariado&#44; apenas a DBP foi confirmada como fator de risco independente &#40;raz&#227;o de taxas de incid&#234;ncia &#40;RTI&#41; ajustada&#44; 2&#44;77&#41;&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">An&#225;lises adicionais foram feitas no subgrupo de 134 pacientes com DBP&#59; 28 pacientes com DBP apresentaram 32 epis&#243;dios de interna&#231;&#227;o relacionada a ITRI e nove epis&#243;dios foram confirmados como relacionados &#224; infec&#231;&#227;o por VSR&#46; A taxa de interna&#231;&#227;o devida a ITRI foi de 26&#44;4 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 17&#44;1&#8208;35&#44;8&#41; e a taxa de interna&#231;&#227;o devida ao VSR foi de 7&#44;4 em cada 100 pacientes&#8208;ano &#40;IC de 95&#37;&#44; 2&#44;7&#8208;12&#44;1&#41;&#46;</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Eventos adversos durante o tratamento com palivizumabe</span><p id="par0100" class="elsevierStylePara elsevierViewall">Foram registrados 1&#46;165 eventos adversos durante um ano de acompanhamento&#59; 102 pacientes &#40;22&#44;3&#37;&#41; apresentaram 135 eventos adversos graves&#46; A <a class="elsevierStyleCrossRef" href="#tbl0020">tabela 4</a> apresenta os eventos adversos n&#227;o graves &#40;&#8805; 5&#37; dos pacientes&#41; relatados no estudo &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>299&#41;&#46; Dos eventos adversos graves relatados&#44; o mais comum &#40;&#8805; 5&#37; dos pacientes&#41; foi a bronquiolite &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>28&#59; 6&#44;1&#37;&#41;&#46; Adicionalmente&#44; 92 eventos adversos graves &#40;68&#44;1&#37;&#41; resultaram em ou prolongaram o tempo de interna&#231;&#227;o&#44; 29 &#40;21&#44;4&#37;&#41; foram classificados pelo investigador como clinicamente relevantes e 11 &#40;8&#44;1&#37;&#41; foram possivelmente fatais&#46; Tr&#234;s &#243;bitos &#40;2&#44;2&#37;&#41; foram registrados durante o acompanhamento e n&#227;o foram considerados relacionados ao tratamento com palivizumabe ou &#224; infec&#231;&#227;o por VSR&#46; Foram relatados seis eventos de dor no local da inje&#231;&#227;o ap&#243;s a administra&#231;&#227;o de palivizumabe em tr&#234;s pacientes&#46; N&#227;o ocorreram eventos adversos graves considerados relacionados ao palivizumabe&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Discuss&#227;o</span><p id="par0105" class="elsevierStylePara elsevierViewall">O palivizumabe &#233; aprovado para a profilaxia de doen&#231;a grave por VSR&#44; com efic&#225;cia comprovada na redu&#231;&#227;o de interna&#231;&#245;es de neonatos de alto risco&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;13</span></a> Contudo&#44; uma profilaxia consistente pode ser desafiadora devido a diversos fatores m&#233;dicos e socioecon&#244;micos da crian&#231;a&#46;<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">18&#44;19</span></a> Este estudo apresentou uma descri&#231;&#227;o prospectiva do uso e da efic&#225;cia do palivizumabe nos pa&#237;ses da Am&#233;rica Latina&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">A taxa de interna&#231;&#245;es por VSR observada no estudo &#40;2&#44;9 em cada 100 pacientes&#8208;ano&#41; &#233; baixa e est&#225; no intervalo relatado com rela&#231;&#227;o ao palivizumabe em diferentes ensaios cl&#237;nicos &#40;0&#44;0&#8208;5&#44;3&#37;&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;13&#44;20</span></a> Adicionalmente&#44; os resultados deste estudo tamb&#233;m s&#227;o compat&#237;veis com os de outros estudos observacionais &#40;1&#44;3&#8208;2&#44;9 epis&#243;dios em cada 100 pacientes&#8208;ano&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">12&#44;21&#44;22</span></a> Por outro lado&#44; existem poucos dados sobre as taxas de interna&#231;&#227;o por VSR em neonatos sem a profilaxia com palivizumabe na Am&#233;rica Latina&#46; Um estudo de um hospital p&#250;blico da Argentina mostrou que neonatos sem a profilaxia com palivizumabe apresentaram taxas de interna&#231;&#227;o por VSR&#8208;ITRI de 26&#37; e 29&#37; em duas coortes hist&#243;ricas&#46;<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">23</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Foi mostrado que as taxas de interna&#231;&#227;o por VSR em pacientes com profilaxia com palivizumabe podem chegar a 7&#44;6&#37; em algumas circunst&#226;ncias&#44; principalmente em pacientes com DBP&#46;<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">13&#44;18&#44;23</span></a> De fato&#44; neste estudo&#44; uma taxa de interna&#231;&#227;o por VSR de 7&#44;4 em cada 100 pacientes&#8208;ano foi observada em crian&#231;as com DBP&#44; achado em linha com resultados relatados anteriormente&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">18</span></a> A mediana do tempo de interna&#231;&#227;o devido a doen&#231;as causadas pelo VSR foi de sete dias&#44; resultado semelhante &#224;quele observado em estudos de outros pa&#237;ses<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">22&#44;24</span></a> e a achados do estudo de Bauer et al&#46; em um &#250;nico centro na Argentina&#46;<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">23</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">A incid&#234;ncia e a gravidade da infec&#231;&#227;o por VSR em neonatos prematuros foram associadas a diversos fatores&#44; como a presen&#231;a de irm&#227;os em casa e frequ&#234;ncia em creche&#44; entre outros&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">6&#44;25</span></a> Um estudo de coorte prospectivo com 152 neonatos internados por ITRI mostrou que o baixo peso ao nascer&#44; o baixo n&#237;vel de escolaridade da m&#227;e e as baixas condi&#231;&#245;es socioecon&#244;micas eram fatores de risco associados &#224;s interna&#231;&#245;es por VSR em neonatos prematuros e nascidos a termo sem instabilidade hemodin&#226;mica&#44; doen&#231;as card&#237;acas ou doen&#231;a pulmonar cr&#244;nica no Brasil&#46;<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">26</span></a> Na Argentina&#44; Bauer et al&#46; tamb&#233;m observaram que crian&#231;as com menos de 10 anos em casa e m&#227;es que n&#227;o conclu&#237;ram o ensino fundamental estavam associadas ao aumento do risco de interna&#231;&#227;o por VSR entre neonatos prematuros com e sem DBP&#46;<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">27</span></a> Ademais&#44; alguns estudos mostraram aumento no risco de ITRI devido &#224; exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em casa&#44; embora seja necess&#225;ria uma pesquisa adicional para determinar seu impacto sobre a gravidade da ITRI por VSR&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">6</span></a> No presente estudo&#44; apenas a DBP foi identificada como fator de risco independente da interna&#231;&#227;o por ITRI&#44; ao passo que outros fatores n&#227;o estavam associados ao aumento do risco&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">No que diz respeito &#224; seguran&#231;a&#44; nenhum evento adverso grave relacionado ao palivizumabe foi relatado em nosso estudo&#46; O padr&#227;o e o tipo de eventos adversos foram compat&#237;veis com o perfil de seguran&#231;a conhecido do palivizumabe&#44; que normalmente reflete os problemas m&#233;dicos subjacentes desses pacientes&#46;<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">8&#44;12&#44;18&#44;28</span></a> De maneira semelhante a outros estudos&#44; as infec&#231;&#245;es respirat&#243;rias do trato superior foram os eventos adversos mais frequentes&#44; com propor&#231;&#227;o compar&#225;vel &#224;quela relatada em um estudo brasileiro &#40;59&#44;4&#37; em compara&#231;&#227;o com 52&#44;8&#37; em nosso estudo&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">29</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Este estudo teve algumas limita&#231;&#245;es&#44; como ocorre em estudos observacionais&#46; Como n&#227;o teve controle&#44; n&#227;o fornece uma estimativa t&#227;o clara do impacto da profilaxia com palivizumabe como os resultados obtidos por meio de ensaios cl&#237;nicos comparativos randomizados&#46;<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">24</span></a> Al&#233;m disso&#44; nem todas as interna&#231;&#245;es passaram por um exame diagn&#243;stico para confirmar se o epis&#243;dio foi causado por uma infec&#231;&#227;o por VSR&#46; Contudo&#44; como o teste de VSR depende das diretrizes locais e n&#227;o era sempre feito&#44; esses resultados devem ser interpretados com cautela&#46; Isso ocorre devido principalmente &#224; variabilidade entre os locais participantes no que diz respeito &#224;s diretrizes locais sobre testes de diagn&#243;stico&#44; limita&#231;&#227;o que tamb&#233;m estava presente em estudos semelhantes do mundo real&#46;<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">21&#44;24&#44;30</span></a> A falta de informa&#231;&#245;es tamb&#233;m pode ser um fator em alguns casos em que a interna&#231;&#227;o ocorreu em um hospital n&#227;o envolvido no estudo&#46; Contudo&#44; foram envidados esfor&#231;os para coletar dados a respeito da presen&#231;a de VSR nesses casos&#46; Por fim&#44; outra limita&#231;&#227;o foi que eventos adversos n&#227;o graves n&#227;o foram classificados pelos investigadores como relacionados ou n&#227;o ao palivizumabe&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">Embora os locais participantes n&#227;o representem totalmente a popula&#231;&#227;o geral de pacientes que recebem a profilaxia em pa&#237;ses da Am&#233;rica Latina&#44; eles foram selecionados com base em sua capacidade de inscri&#231;&#245;es e experi&#234;ncia com o palivizumabe e o tratamento de crian&#231;as de alto risco&#46; Por outro lado&#44; como os pais das crian&#231;as precisavam ter acesso ao sistema de sa&#250;de&#44; um vi&#233;s de sele&#231;&#227;o pode afetar algumas vari&#225;veis&#44; como a ades&#227;o ao tratamento e o n&#237;vel de escolaridade&#44; que de outra forma poderiam estar associadas &#224;s interna&#231;&#245;es por ITRI&#46; Por fim&#44; embora a incid&#234;ncia e a gravidade da infec&#231;&#227;o por VSR sejam afetadas pela sazonalidade&#44;<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">25</span></a> isso n&#227;o deve comprometer os principais achados&#46; Este estudo foi feito durante dois anos consecutivos &#40;incluindo mais de uma esta&#231;&#227;o de VSR&#41; em diferentes cidades e pa&#237;ses&#44; fornece&#44; assim&#44; uma vis&#227;o geral da regi&#227;o da Am&#233;rica Latina&#44; ao mesmo tempo em que abrange a maioria de seus padr&#245;es de sazonalidade de VSR&#46; Na verdade&#44; at&#233; onde sabemos&#44; este &#233; o primeiro estudo multic&#234;ntrico que incluiu neonatos que receberam profilaxia na regi&#227;o da Am&#233;rica Latina&#44; com a vantagem da coleta de dados demogr&#225;ficos e cl&#237;nicos completos de praticamente todas as crian&#231;as inscritas&#44; embora outros estudos em um &#250;nico centro e com um acompanhamento mais curto tenham sido feitos nessa regi&#227;o&#46;</p><p id="par0140" class="elsevierStylePara elsevierViewall">A taxa de interna&#231;&#227;o devida a infec&#231;&#227;o por VSR foi baixa nessa popula&#231;&#227;o e em linha com as observadas em v&#225;rios ensaios cl&#237;nicos controlados randomizados e estudos observacionais&#46; Com base em nosso estudo&#44; a profilaxia com palivizumabe &#233; eficaz e tem um bom perfil de seguran&#231;a em neonatos da Am&#233;rica Latina com alto risco de infec&#231;&#227;o grave por VSR&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Financiamento</span><p id="par0145" class="elsevierStylePara elsevierViewall">Este estudo foi financiado por AbbVie&#44; Inc&#46;</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Conflitos de interesse</span><p id="par0150" class="elsevierStylePara elsevierViewall">N Vain recebeu uma bolsa&#47;apoio &#224; pesquisa e honor&#225;rios de palestrante e consultoria da AbbVie&#46; M E Serra &#233; funcion&#225;ria da Fundasamin&#44; contratada pela AbbVie para Gest&#227;o de Dados do Estudo&#46; A AbbVie Inc&#46; esteve envolvida no modelo do estudo&#59; na coleta&#44; an&#225;lise e interpreta&#231;&#227;o de dados&#59; e na prepara&#231;&#227;o e aprova&#231;&#227;o deste manuscrito&#46; L&#46; Castillo e G&#46; Bugarin s&#227;o funcion&#225;rios da AbbVie e podem deter a&#231;&#245;es ou op&#231;&#245;es&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:12 [
        0 => array:3 [
          "identificador" => "xres904278"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Objective"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Method"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec884873"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres904279"
          "titulo" => "Resumo"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Objetivo"
            ]
            1 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "M&#233;todo"
            ]
            2 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Conclus&#245;es"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec884874"
          "titulo" => "Palavras&#8208;chave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introdu&#231;&#227;o"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "M&#233;todos"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Modelo do estudo"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Crit&#233;rios de elegibilidade"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Acompanhamento e coleta de dados"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "An&#225;lise de seguran&#231;a"
            ]
            4 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "An&#225;lise estat&#237;stica"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0040"
          "titulo" => "Resultados"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Caracter&#237;sticas da amostra"
            ]
            1 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Uso e ades&#227;o do paciente ao palivizumabe"
            ]
            2 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Interna&#231;&#245;es devido &#224; ITRI"
            ]
            3 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Eventos adversos durante o tratamento com palivizumabe"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Discuss&#227;o"
        ]
        8 => array:2 [
          "identificador" => "sec0070"
          "titulo" => "Financiamento"
        ]
        9 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conflitos de interesse"
        ]
        10 => array:2 [
          "identificador" => "xack301132"
          "titulo" => "Agradecimentos"
        ]
        11 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-07-26"
    "fechaAceptado" => "2016-11-09"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec884873"
          "palabras" => array:5 [
            0 => "Palivizumab"
            1 => "Prophylaxis"
            2 => "Respiratory syncytial virus"
            3 => "Lower respiratory tract infection"
            4 => "Latin America"
          ]
        ]
      ]
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras&#8208;chave"
          "identificador" => "xpalclavsec884874"
          "palabras" => array:5 [
            0 => "Palivizumabe"
            1 => "Profilaxia"
            2 => "V&#237;rus sincicial respirat&#243;rio"
            3 => "Infec&#231;&#227;o do trato respirat&#243;rio inferior"
            4 => "Am&#233;rica Latina"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">This study aims to describe real world palivizumab use and effectiveness in high&#8208;risk Latin American infants and young children&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Method</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Prospective&#44; multicenter observational study with infants at risk for severe RSV infection who received palivizumab according to routine clinical practice&#46; Subjects were followed for one year with monthly visits after the first dose of palivizumab&#46; An infant was considered adherent if receiving all the expected injections or five or fewer injections within appropriate inter&#8208;dose intervals&#46; Annual incidence rates and risk factors of lower respiratory tract infection &#40;LRTI&#41; hospitalization were determined through Poisson regression models &#40;<span class="elsevierStyleItalic">&#945;</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#41;&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The study enrolled 458 children from seven countries in Latin America&#44; from February 2011 to September 2012&#46; The majority &#40;98&#37;&#41; were born &#60;36 weeks gestation&#46; Overall&#44; patients received 83&#46;7&#37; of their expected injections and 86&#46;7&#37; completed one year of follow&#8208;up&#46; Of the 61 LRTI hospitalizations&#44; 12 episodes were due to RSV infection&#46; The RSV&#8208;associated hospitalization rate was 2&#46;9 per 100 patient&#8208;years&#46; Bronchopulmonary dysplasia was identified as an independent risk factor for LRTI hospitalization&#46; A total of 1165 adverse events were recorded during one year of follow&#8208;up&#46; One hundred and two patients &#40;22&#46;3&#37;&#41; had a total of 135 serious adverse events&#44; but no events were considered to be related to palivizumab&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The rate of RSV hospitalization in high&#8208;risk infants in Latin America was low and aligned with those observed in randomized control trials and observational studies&#46; Palivizumab prophylaxis appeared effective and had a good safety profile in this population&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Objective"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Method"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "pt" => array:3 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Descrever o uso e a efic&#225;cia do palivizumabe no mundo real em neonatos e jovens crian&#231;as de alto risco latino&#8208;americanas&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">M&#233;todo</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Estudo observacional prospectivo multic&#234;ntrico com neonatos em risco devido a infec&#231;&#227;o grave por VSR que receberam palivizumabe de acordo com a pr&#225;tica cl&#237;nica de rotina&#46; Os indiv&#237;duos foram acompanhados por um ano&#44; com visitas mensais ap&#243;s a primeira dose de palivizumabe&#46; Um neonato foi considerado adepto se recebeu todas as inje&#231;&#245;es esperadas ou &#8804; 5 inje&#231;&#245;es nos intervalos entre doses adequados&#46; As taxas de incid&#234;ncia anuais e os fatores de risco de interna&#231;&#227;o por infec&#231;&#227;o do trato respirat&#243;rio inferior &#40;ITRI&#41; foram determinados por meio dos modelos de regress&#227;o de Poisson &#40;&#945;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#41;&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">O estudo inscreveu 458 crian&#231;as de sete pa&#237;ses da Am&#233;rica Latina&#44; de fevereiro de 2011 a setembro de 2012&#46; A maioria &#40;98&#37;&#41; nasceu com &#60; 36 semanas&#46; Em geral&#44; os pacientes receberam 83&#44;7&#37; de suas inje&#231;&#245;es esperadas e 86&#44;7&#37; completaram um ano de acompanhamento&#46; Das 61 interna&#231;&#245;es por ITRI&#44; 12 epis&#243;dios foram devidos a infec&#231;&#227;o por VSR&#46; A taxa de interna&#231;&#227;o associada ao VSR foi de 2&#44;9 em cada 100 pacientes&#8208;ano&#46; A displasia broncopulmonar foi identificada como um fator de risco independente da interna&#231;&#227;o por ITRI&#46; Foram registrados 1&#46;165 eventos adversos durante um ano de acompanhamento&#59; 122 &#40;22&#44;3&#37;&#41; apresentaram 135 eventos adversos graves&#44; por&#233;m nenhum deles foi considerado relacionado ao palivizumabe&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclus&#245;es</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">A taxa de interna&#231;&#227;o por VSR em neonatos de alto risco na Am&#233;rica Latina foi baixa e em linha com as observadas em ensaios cl&#237;nicos controlados randomizados e estudos observacionais&#46; A profilaxia com palivizumabe pareceu eficaz e com bom perfil de seguran&#231;a nessa popula&#231;&#227;o&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Objetivo"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "M&#233;todo"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Conclus&#245;es"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0040">Como citar este artigo&#58; Castillo LM&#44; Bugarin G&#44; Arias JC&#44; Rangel JI&#44; Serra ME&#44; Vain N&#46; One&#8208;year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America&#46; J Pediatr &#40;Rio J&#41;&#46; 2017&#59;93&#58;467&#8211;74&#46;</p>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">CC&#58; cardiopatia cong&#234;nita&#59; DBP&#44; displasia broncopulmonar&#59; DP&#58; desvio padr&#227;o&#59; IIQ&#58; intervalo interquartil&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Pa&#237;s de inscri&#231;&#227;o&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Argentina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">149 &#40;32&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Col&#244;mbia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">147 &#40;32&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>M&#233;xico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100 &#40;21&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Chile&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32 &#40;7&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Peru&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;2&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Uruguai&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 &#40;2&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Equador&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;1&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Masculino&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">239 &#40;52&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade &#40;dias&#41; na primeira dose&#44; mediana &#40;IIQ&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55 &#40;31&#8208;99&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Peso ao nascer &#40;g&#41;&#44; m&#233;dia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#177;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">DP</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1344&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>460&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;&#44; mediana &#40;IIQ&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31 &#40;28&#8208;32&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">287 &#40;62&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 29 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">118 &#40;25&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>29&#8208;32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">169 &#40;36&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>32&#8208;35 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">163 &#40;35&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#62; 35 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8 &#40;1&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Prematuridade&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">449 &#40;98&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Somente prematuridade&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">296 &#40;64&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">112 &#40;24&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;3&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prematuridade<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>DBP e&#47;ou CC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">153 &#40;33&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DBP&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">134 &#40;29&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">CC&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46 &#40;10&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">M&#227;e com primeiro grau completo&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">443 &#40;96&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Tabagismo durante a gravidez&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;19&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">M&#227;e asm&#225;tica&#47;at&#243;pica&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55 &#40;12&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Nascimento m&#250;ltiplo&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">141 &#40;30&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Amamenta&#231;&#227;o aos 3 meses de idade</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">222 &#40;49&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Outras crian&#231;as na casa &#8804; 6 anos&#44; n &#40;5&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">160 &#40;34&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Exposi&#231;&#227;o &#224; fuma&#231;a de cigarro em casa&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">78 &#40;17&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Frequ&#234;ncia em creche&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 &#40;1&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Assist&#234;ncia m&#233;dica pr&#233;&#8208;natal</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">386 &#40;84&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Interna&#231;&#227;o na unidade de terapia intensiva neonatal&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">447 &#40;97&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Ventila&#231;&#227;o mec&#226;nica neonatal&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">257 &#40;56&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Ades&#227;o ao tratamento com palivizumabe&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">383 &#40;83&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Doses administradas por paciente&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>5 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">200 &#40;43&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>4 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">66 &#40;14&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>3 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">130 &#40;28&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>2 doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28 &#40;6&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>1 dose&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">34 &#40;7&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Pacientes recebendo as doses esperadas&#44; n &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Acima do esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">29 &#40;6&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Como esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">240 &#40;52&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Abaixo do esperado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">189 &#40;41&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Fornecedor do palivizumabe &#40;n</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#61;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">1&#46;707 doses&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Plano de sa&#250;de privado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">814 &#40;47&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Sistema p&#250;blico de sa&#250;de&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">669 &#40;39&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Previd&#234;ncia social&#47;Sociedade de Apoio M&#250;tuo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">207 &#40;12&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Desembolsado pelo paciente&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;1&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520458.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">A amamenta&#231;&#227;o foi analisada aos tr&#234;s meses de 449 pacientes&#58; 222 neonatos &#40;49&#44;4&#37;&#41; recebiam amamenta&#231;&#227;o&#44; com 49 neonatos &#40;10&#44;9&#37;&#41; que recebiam apenas amamenta&#231;&#227;o e 173 neonatos &#40;38&#44;5&#37;&#41; que recebiam amamenta&#231;&#227;o n&#227;o exclusiva&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">A assist&#234;ncia m&#233;dica pr&#233;&#8208;natal foi definida como quatro ou mais consultas m&#233;dicas durante a gravidez&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas demogr&#225;ficas&#44; cl&#237;nicas e de tratamento da popula&#231;&#227;o estudada &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>458&#41;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabela 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">CC&#58; cardiopatia cong&#234;nita&#59; DBP&#58; displasia broncopulmonar&#59; DP&#58; desvio padr&#227;o&#59; IC&#58; intervalo de confian&#231;a&#59; ITRI&#58; infec&#231;&#227;o do trato respirat&#243;rio inferior&#59; VSR&#58; v&#237;rus sincicial respirat&#243;rio&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Epis&#243;dios de ITRI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Epis&#243;dios de ITRI relacionados ao VSR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Crian&#231;as com no m&#237;nimo uma interna&#231;&#227;o&#44; n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&#47;458 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#47;458 &#40;2&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Taxa de interna&#231;&#227;o &#40;IC de 95&#37;&#41; a cada 100 pacientes&#44; anos</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#44;6 &#40;10&#44;5&#8208;18&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;9 &#40;1&#44;3&#8208;4&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">N&#250;mero de interna&#231;&#245;es</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Tempo de interna&#231;&#227;o &#40;dias&#41;</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">mediana &#40;faixa&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 &#40;1&#8208;43&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;5&#8208;21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Apoio respirat&#243;rio</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4 &#40;6&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade gestacional &#40;semanas&#41;</span>&#44;<a class="elsevierStyleCrossRefs" href="#tblfn0015"><span class="elsevierStyleSup">a&#44;b</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 32 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41 &#40;67&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6 &#40;50&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>&#60; 29 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20 &#40;32&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4 &#40;33&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>30&#8208;31 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21 &#40;34&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2 &#40;16&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>32&#8208;34 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20 &#40;32&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6 &#40;50&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DBP</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32 &#40;52&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;75&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">CC</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">n &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;8&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Idade no epis&#243;dio &#40;dias&#41;</span>&#44;<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleItalic">m&#233;dia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#177;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">DP</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">236&#44;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>120&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">224&#44;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>115&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520459.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Os percentuais foram calculados pelo total de epis&#243;dios de interna&#231;&#227;o devido a ITRI &#40;geral e relacionada ao VSR&#41;&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Todos os pacientes com epis&#243;dios de ITRI tinham idade gestacional inferior a 35 semanas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Caracteriza&#231;&#227;o dos epis&#243;dios de interna&#231;&#227;o devido a ITRI</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabela 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">IC&#44; intervalo de confian&#231;a&#59; ITRI&#58; infec&#231;&#227;o do trato respirat&#243;rio inferior&#59; RTI&#58; raz&#227;o de taxa de incid&#234;ncia&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">O texto em negrito &#233; considerado significativo&#59; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Covari&#225;veis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">RTI bruta &#40;IC de 95&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">RTI ajustada &#40;IC de 95&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">P&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sexo feminino &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>masculino&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92 &#40;0&#44;55&#8208;1&#44;53&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;744&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;54&#8208;1&#44;57&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;773&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Idade gestacional &#40;semanas&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;84&#8208;1&#44;02&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;02<br>&#40;0&#44;87&#8208;1&#44;21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;795&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Displasia broncopulmonar &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;77<br>&#40;1&#44;67&#8208;4&#44;60&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#60; 0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;75<br>&#40;1&#44;53&#8208;4&#44;96&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiopatia cong&#234;nita &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;15<br>&#40;0&#44;49&#8208;2&#44;67&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;747&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;92<br>&#40;0&#44;38&#8208;2&#44;26&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;864&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tabagismo<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">a</span></a> &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>n&#227;o&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;55<br>&#40;0&#44;80&#8208;8&#44;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;115&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;36<br>&#40;0&#44;38&#8208;4&#44;89&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;637&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Peso ao nascer &#40;g&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;00&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;167&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;99<br>&#40;0&#44;99&#8208;1&#44;00&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;643&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ades&#227;o ao tratamento<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">b</span></a> &#40;percentual&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;371&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;00<br>&#40;0&#44;99&#8208;1&#44;01&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;290&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">M&#227;e com primeiro grau completo &#40;refer&#234;ncia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>sim&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;11<br>&#40;1&#44;04&#8208;4&#44;28&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;039&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;84<br>&#40;0&#44;85&#8208;3&#44;99&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;123&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520457.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0025"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0025">O &#8220;tabagismo&#8221; &#233; uma combina&#231;&#227;o das vari&#225;veis tabagismo em casa e tabagismo durante a gravidez&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0030"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Ades&#227;o&#58; percentual &#40;&#37;&#41; de doses recebidas em compara&#231;&#227;o com as esperadas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Fatores de risco de interna&#231;&#245;es por ITRI</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Tabela 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">MedDRA&#44; Dicion&#225;rio M&#233;dico para Atividades Regulat&#243;rias&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleBold">Eventos adversos graves</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Infec&#231;&#245;es e infesta&#231;&#245;es</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Bronquiolite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28 &#40;6&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleBold">Eventos adversos n&#227;o graves</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Dist&#250;rbios gastrointestinais</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Diarreia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">52 &#40;11&#44;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Dist&#250;rbios gerais</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Pirexia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">49 &#40;10&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Infec&#231;&#245;es e infesta&#231;&#245;es</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Bronquiolite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">71 &#40;15&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Otite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Infec&#231;&#227;o do trato respirat&#243;rio superior&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">242 &#40;52&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Doen&#231;as respirat&#243;rias&#44; tor&#225;cicas e do mediastino</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Broncoespasmo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">73 &#40;15&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="char" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Doen&#231;as da pele e do tecido subcut&#226;neo</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Dermatite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Erup&#231;&#227;o cut&#226;nea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23 &#40;5&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1520460.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0035"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0035">Os indiv&#237;duos podem ter apresentado mais de um evento adverso &#40;n&#237;vel de termo preferencial do MedDRA&#41;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Eventos adversos graves e n&#227;o graves mais comuns &#40;&#8805; 5&#37; dos indiv&#237;duos&#41;<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">a</span></a></p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:30 [
            0 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010&#58; a systematic analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "E&#46;A&#46; Sim&#245;es"
                            2 => "I&#46; Rudan"
                            3 => "B&#46;D&#46; Gessner"
                            4 => "E&#46; Azziz-Baumgartner"
                            5 => "J&#46;S&#46; Zhang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(12)61901-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2013"
                        "volumen" => "381"
                        "paginaInicial" => "1380"
                        "paginaFinal" => "1390"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23369797"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children&#58; a systematic review and meta&#8208;analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "D&#46;J&#46; Nokes"
                            2 => "B&#46;D&#46; Gessner"
                            3 => "M&#46; Dherani"
                            4 => "S&#46;A&#46; Madhi"
                            5 => "R&#46;J&#46; Singleton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60206-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "375"
                        "paginaInicial" => "1545"
                        "paginaFinal" => "1555"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20399493"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A decade of respiratory syncytial virus epidemiology and prophylaxis&#58; translating evidence into everyday clinical practice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46;A&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Banerji"
                            3 => "K&#46;L&#46; Lanct&#244;t"
                            4 => "J&#46;M&#46; Langley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Can Respir J"
                        "fecha" => "2011"
                        "volumen" => "18"
                        "paginaInicial" => "e10"
                        "paginaFinal" => "e19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21499597"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review and meta&#8208;analysis of respiratory syncytial virus infection epidemiology in Latin America"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Bardach"
                            1 => "L&#46; Rey-Ares"
                            2 => "M&#46;L&#46; Cafferata"
                            3 => "G&#46; Cormick"
                            4 => "M&#46; Romano"
                            5 => "S&#46; Ruvinsky"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Med Virol"
                        "fecha" => "2014"
                        "volumen" => "24"
                        "paginaInicial" => "76"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24757727"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus&#58; clinical and epidemiological pattern in pediatric patients admitted to a children&#39;s hospital between 2000 and 2013"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;F&#46; Lucion"
                            1 => "V&#46; Juarez Mdel"
                            2 => "M&#46; Viegas"
                            3 => "V&#46; Castellano"
                            4 => "V&#46;S&#46; Romanin"
                            5 => "M&#46; Grobaporto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5546/aap.2014.397"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2014"
                        "volumen" => "112"
                        "paginaInicial" => "397"
                        "paginaFinal" => "404"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25192519"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk factors for severe respiratory syncytial virus lower respiratory tract infection"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Sommer"
                            1 => "B&#46; Resch"
                            2 => "E&#46;A&#46; Sim&#245;es"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2174/1874285801105010144"
                      "Revista" => array:6 [
                        "tituloSerie" => "Open Microbiol J"
                        "fecha" => "2011"
                        "volumen" => "5"
                        "paginaInicial" => "144"
                        "paginaFinal" => "154"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22262987"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A population&#8208;weighted&#44; condition&#8208;adjusted estimate of palivizumab efficacy in preventing RSV&#8208;related hospitalizations among US high&#8208;risk children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46;S&#46; Ambrose"
                            1 => "X&#46; Chen"
                            2 => "V&#46;R&#46; Kumar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4161/hv.32082"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hum Vaccin Immunother"
                        "fecha" => "2014"
                        "volumen" => "10"
                        "paginaInicial" => "2785"
                        "paginaFinal" => "2788"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25483483"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Palivizumab&#44; a humanized respiratory syncytial virus monoclonal antibody&#44; reduces hospitalization from respiratory syncytial virus infection in high&#8208;risk infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "The IMpact-RSV Study Group"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "1998"
                        "volumen" => "102"
                        "paginaInicial" => "531"
                        "paginaFinal" => "537"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9738173"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy&#44; 1998&#8211;2008"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;R&#46; Groothuis"
                            1 => "J&#46;P&#46; Fryzek"
                            2 => "D&#46; Makari"
                            3 => "D&#46; Steffey"
                            4 => "W&#46;J&#46; Martone"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2147/CLEP.S17189"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Epidemiol"
                        "fecha" => "2011"
                        "volumen" => "3"
                        "paginaInicial" => "245"
                        "paginaFinal" => "250"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22003308"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants&#58; a prospective birth cohort study in Brazil"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Arruda"
                            1 => "M&#46;H&#46; Jones"
                            2 => "F&#46; Escremim de Paula"
                            3 => "D&#46; Chong"
                            4 => "G&#46; Bugarin"
                            5 => "G&#46; Notario"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/INF.0000000000000349"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Infect Dis J"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "997"
                        "paginaFinal" => "1003"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25361184"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An evaluation of the emerging interventions against respiratory syncytial virus &#40;RSV&#41;&#8208;associated acute lower respiratory infections in children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Nair"
                            1 => "V&#46;R&#46; Verma"
                            2 => "E&#46; Theodoratou"
                            3 => "L&#46; Zgaga"
                            4 => "T&#46; Huda"
                            5 => "E&#46;A&#46; Sim&#245;es"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/1471-2458-11-S3-S30"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Public Health"
                        "fecha" => "2011"
                        "volumen" => "11"
                        "paginaInicial" => "S30"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21501449"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and effectiveness of palivizumab in children at high risk of serious disease due to respiratory syncytial virus infection&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Wegzyn"
                            1 => "L&#46;K&#46; Toh"
                            2 => "G&#46; Notario"
                            3 => "S&#46; Biguenet"
                            4 => "K&#46; Unnebrink"
                            5 => "C&#46; Park"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s40121-014-0046-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Infect Dis Ther"
                        "fecha" => "2014"
                        "volumen" => "3"
                        "paginaInicial" => "133"
                        "paginaFinal" => "158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25297809"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;F&#46; Feltes"
                            1 => "A&#46;K&#46; Cabalka"
                            2 => "H&#46;C&#46; Meissner"
                            3 => "F&#46;M&#46; Piazza"
                            4 => "D&#46;A&#46; Carlin"
                            5 => "F&#46;H&#46; Top Jr&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2003"
                        "volumen" => "143"
                        "paginaInicial" => "532"
                        "paginaFinal" => "540"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14571236"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The epidemiology and clinical characteristics of respiratory syncytial virus infection in children at a public pediatric referral hospital in Mexico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;P&#46; Rodr&#237;guez-Auad"
                            1 => "M&#46; Nava-Fr&#237;as"
                            2 => "J&#46; Casasola-Flores"
                            3 => "K&#46;M&#46; Johnson"
                            4 => "A&#46; Nava-Ruiz"
                            5 => "V&#46; P&#233;rez-Robles"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijid.2012.03.001"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Infect Dis"
                        "fecha" => "2012"
                        "volumen" => "16"
                        "paginaInicial" => "e508"
                        "paginaFinal" => "e513"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22525227"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus infection in Guatemala&#44; 2007&#8211;2012"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;P&#46; McCracken"
                            1 => "M&#46;M&#46; Prill"
                            2 => "W&#46; Arvelo"
                            3 => "K&#46;A&#46; Lindblade"
                            4 => "M&#46;R&#46; L&#243;pez"
                            5 => "A&#46; Estevez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/infdis/jit517"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Infect Dis"
                        "fecha" => "2013"
                        "volumen" => "208"
                        "paginaInicial" => "S197"
                        "paginaFinal" => "S206"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24265479"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidence and clinical characteristics of the infection by the respiratory syncytial virus in children admitted in Santa Casa de S&#227;o Paulo Hospital"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Pecchini"
                            1 => "E&#46;N&#46; Berezin"
                            2 => "M&#46;C&#46; Fel&#237;cio"
                            3 => "S&#46;D&#46; Passos"
                            4 => "M&#46;C&#46; Souza"
                            5 => "L&#46;R&#46; Lima"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Braz J Infect Dis"
                        "fecha" => "2008"
                        "volumen" => "12"
                        "paginaInicial" => "476"
                        "paginaFinal" => "479"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19287833"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile &#40;1989 to 2000&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46;F&#46; Avenda&#241;o"
                            1 => "M&#46;A&#46; Palomino"
                            2 => "C&#46; Larra&#241;aga"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Microbiol"
                        "fecha" => "2003"
                        "volumen" => "41"
                        "paginaInicial" => "4879"
                        "paginaFinal" => "4882"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14532249"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "French Pediatricians&#8217; Group of Sunagis Patients&#8217; Name&#8208;Based Programs&#46; Incidence of respiratory syncytial virus&#8208;related hospitalizations in high&#8208;risk children&#58; follow&#8208;up of a national cohort of infants treated with Palivizumab as RSV prophylaxis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "T&#46; Lacaze-Masmonteil"
                            1 => "J&#46;C&#46; Roz&#233;"
                            2 => "B&#46; Fauroux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ppul.10175"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Pulmonol"
                        "fecha" => "2002"
                        "volumen" => "34"
                        "paginaInicial" => "181"
                        "paginaFinal" => "188"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12203846"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bronchopulmonary dysplasia&#58; incidence&#44; risk factors and resource utilization in a population of South American very low birth weight infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Tapia"
                            1 => "D&#46; Agost"
                            2 => "A&#46; Alegria"
                            3 => "J&#46; Standen"
                            4 => "M&#46; Escobar"
                            5 => "C&#46; Grandi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Pediatr &#40;Rio J&#41;"
                        "fecha" => "2006"
                        "volumen" => "82"
                        "paginaInicial" => "15"
                        "paginaFinal" => "20"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus and recurrent wheeze in healthy preterm infants"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;O&#46; Blanken"
                            1 => "M&#46;M&#46; Rovers"
                            2 => "J&#46;M&#46; Molenaar"
                            3 => "P&#46;L&#46; Winkler-Seinstra"
                            4 => "A&#46; Meijer"
                            5 => "J&#46;L&#46; Kimpen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1211917"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "1791"
                        "paginaFinal" => "1799"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23656644"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of hospitalization due to respiratory syncytial virus&#58; results from the Palivizumab Outcomes Registry"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Frogel"
                            1 => "C&#46; Nerwen"
                            2 => "A&#46; Cohen"
                            3 => "P&#46; VanVeldhuisen"
                            4 => "M&#46; Harrington"
                            5 => "M&#46; Boron"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/jp.2008.28"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Perinatol"
                        "fecha" => "2008"
                        "volumen" => "28"
                        "paginaInicial" => "511"
                        "paginaFinal" => "517"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18368063"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "CARESS Investigators&#46; A comparative study of respiratory syncytial virus &#40;RSV&#41; prophylaxis in premature infants within the Canadian Registry of Palivizumab &#40;CARESS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Li"
                            3 => "K&#46;L&#46; Lanct&#244;t"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10096-012-1617-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Microbiol Infect Dis"
                        "fecha" => "2012"
                        "volumen" => "31"
                        "paginaInicial" => "2703"
                        "paginaFinal" => "2711"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22546928"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of a respiratory disease prevention program in high&#8208;risk preterm infants&#58; a prospective&#44; multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Bauer"
                            1 => "L&#46; Bossi"
                            2 => "M&#46; Santoalla"
                            3 => "S&#46; Rodr&#237;guez"
                            4 => "D&#46; Fari&#241;a"
                            5 => "A&#46;M&#46; Speranza"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/S0325-00752009000200004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2009"
                        "volumen" => "107"
                        "paginaInicial" => "111"
                        "paginaFinal" => "118"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19452082"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory&#8208;related hospitalizations following prophylaxis in the Canadian registry for palivizumab &#40;2005&#8211;2012&#41; compared to other international registries"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46; Paes"
                            1 => "I&#46; Mitchell"
                            2 => "A&#46; Li"
                            3 => "T&#46; Harimoto"
                            4 => "K&#46;L&#46; Lanct&#244;t"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2013/917068"
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Dev Immunol"
                        "fecha" => "2013"
                        "volumen" => "2013"
                        "paginaInicial" => "917068"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23861694"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "E&#46;A&#46; Simoes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2003"
                        "volumen" => "143"
                        "paginaInicial" => "S118"
                        "paginaFinal" => "S126"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14615710"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus &#40;RSV&#41; in infants hospitalized for acute lower respiratory tract disease&#58; incidence and associated risks"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;G&#46; Riccetto"
                            1 => "J&#46;D&#46; Ribeiro"
                            2 => "M&#46;T&#46; Silva"
                            3 => "R&#46;S&#46; Almeida"
                            4 => "C&#46;W&#46; Arns"
                            5 => "E&#46;C&#46; Baracat"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Braz J Infect Dis"
                        "fecha" => "2006"
                        "volumen" => "10"
                        "paginaInicial" => "357"
                        "paginaFinal" => "361"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17293926"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Infecci&#243;n por virus sincicial respiratorio en poblaciones vulnerables&#58; riesgo biol&#243;gico contra riesgo social"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46; Bauer"
                            1 => "V&#46; Dussel"
                            2 => "D&#46; Fari&#241;a"
                            3 => "S&#46; Rodr&#237;guez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arch Argent Pediatr"
                        "fecha" => "2005"
                        "volumen" => "103"
                        "paginaInicial" => "198"
                        "paginaFinal" => "204"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of palivizumab in preterm infants 29 to 32 weeks&#8217; gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;R&#46; Groothuis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10096-003-0961-z"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Microbiol Infect Dis"
                        "fecha" => "2003"
                        "volumen" => "22"
                        "paginaInicial" => "414"
                        "paginaFinal" => "417"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12827537"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory infections in children up to two years of age on prophylaxis with palivizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46;I&#46; Monteiro"
                            1 => "N&#46;C&#46; Bellei"
                            2 => "A&#46;R&#46; Sousa"
                            3 => "A&#46;M&#46; dos Santos"
                            4 => "L&#46;Y&#46; Weckx"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Paul Pediatr"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "152"
                        "paginaFinal" => "158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25119744"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Respiratory syncytial virus disease in preterm infants in the U&#46;S&#46; born at 32&#8211;35 weeks gestation not receiving immunoprophylaxis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;S&#46; Ambrose"
                            1 => "E&#46;J&#46; Anderson"
                            2 => "E&#46;A&#46; Sim&#245;es"
                            3 => "X&#46; Wu"
                            4 => "H&#46; Elhefni"
                            5 => "C&#46;L&#46; Park"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/INF.0000000000000219"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Infect Dis J"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "576"
                        "paginaFinal" => "582"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24622396"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack301132"
        "titulo" => "Agradecimentos"
        "texto" => "<p id="par0155" class="elsevierStylePara elsevierViewall">Ao Dr&#46; Guillermo de Jesus Ruelas Orozco&#44; &#224; Dra&#46; Margarita Morales Marquez&#44; Dra&#46; Carolina Salazar e Dra&#46; Adriana Castro e &#224; Sra&#46; Mariana Jacqueline Mart&#237;nez Mu&#241;oz por sua colabora&#231;&#227;o neste estudo&#46; E &#224; Sra&#46; Milene Fernandes &#40;Eurotrials&#44; Scientific Consultants&#41;&#44; que ajudou a redigir este trabalho&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/22555536/0000009300000005/v1_201709220128/S2255553617300277/v1_201709220128/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "16682"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Artigos originais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/22555536/0000009300000005/v1_201709220128/S2255553617300277/v1_201709220128/pt/main.pdf?idApp=UINPBA000049&text.app=https://jped.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300277?idApp=UINPBA000049"
]
Informação do artigo
ISSN: 22555536
Idioma original: Português
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2024 Novembro 4 1 5
2024 Outubro 20 20 40
2024 Setembro 18 17 35
2024 Agosto 28 17 45
2024 Julho 28 32 60
2024 Junho 15 13 28
2024 Maio 13 10 23
2024 Abril 17 18 35
2024 Março 20 20 40
2024 Fevereiro 16 22 38
2024 Janeiro 10 19 29
2023 Dezembro 13 22 35
2023 Novembro 13 28 41
2023 Outubro 20 34 54
2023 Setembro 20 31 51
2023 Agosto 13 12 25
2023 Julho 19 12 31
2023 Junho 12 8 20
2023 Maio 16 16 32
2023 Abril 12 7 19
2023 Março 42 23 65
2023 Fevereiro 14 17 31
2023 Janeiro 15 16 31
2022 Dezembro 41 26 67
2022 Novembro 19 20 39
2022 Outubro 47 38 85
2022 Setembro 22 37 59
2022 Agosto 20 30 50
2022 Julho 25 44 69
2022 Junho 19 42 61
2022 Maio 22 32 54
2022 Abril 57 45 102
2022 Março 34 52 86
2022 Fevereiro 11 30 41
2022 Janeiro 13 20 33
2021 Dezembro 19 24 43
2021 Novembro 12 19 31
2021 Outubro 13 23 36
2021 Setembro 9 7 16
2021 Agosto 4 8 12
2021 Julho 2 4 6
2021 Junho 9 10 19
2021 Maio 7 8 15
2021 Abril 7 8 15
2021 Março 11 12 23
2021 Fevereiro 4 9 13
2021 Janeiro 8 8 16
2020 Dezembro 8 8 16
2020 Novembro 11 14 25
2020 Outubro 11 9 20
2020 Setembro 15 13 28
2020 Agosto 6 4 10
2020 Julho 7 7 14
2020 Junho 9 10 19
2020 Maio 3 3 6
2020 Abril 7 9 16
2020 Março 3 3 6
2020 Fevereiro 10 10 20
2020 Janeiro 6 18 24
2019 Dezembro 6 6 12
2019 Novembro 4 6 10
2019 Outubro 14 18 32
2019 Setembro 13 12 25
2019 Agosto 8 18 26
2019 Julho 15 9 24
2019 Junho 6 13 19
2019 Maio 11 11 22
2019 Abril 17 10 27
2019 Março 6 9 15
2019 Fevereiro 10 7 17
2019 Janeiro 5 7 12
2018 Dezembro 4 8 12
2018 Novembro 35 10 45
2018 Outubro 81 20 101
2018 Setembro 4 6 10
2018 Maio 5 2 7
2018 Abril 32 4 36
2018 Março 26 3 29
2018 Fevereiro 22 4 26
2018 Janeiro 25 3 28
2017 Dezembro 15 2 17
2017 Novembro 37 9 46
2017 Outubro 110 29 139
2017 Setembro 37 12 49
2017 Agosto 3 4 7
2017 Julho 2 1 3
2017 Junho 4 2 6
2017 Maio 5 3 8
2017 Abril 3 2 5
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Jornal de Pediatria
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.